praziquantel has been researched along with Coenuri Infection in 292 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to determine the therapeutic efficacy of albendazole and praziquantel administration in the treatment of neurocysticercosis of the fourth ventricle." | 9.08 | Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. ( Correa, D; García, L; García-Torres, E; Madrazo, I; Proaño, JV, 1997) |
| "Praziquantel and albendazole have been recently described as effective drugs for treatment of intraparenchymal brain cysticercosis." | 9.07 | Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. ( Jardim, E; Takayanagui, OM, 1992) |
| "One hundred consecutive patients presenting with symptoms and signs of neurocysticercosis, confirmed by neuroimaging techniques were randomly assigned to treatment with either praziquantel 50 mg/kg/day for 15 days or albendazole 15 mg/kg/day for 30 days." | 9.07 | Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis. ( Cruz, I; Cruz, M; Horton, J, 1991) |
| "The results of the use of praziquantel (PZQ) for the etiologic treatment of neurocysticercosis (NC) are presented." | 9.06 | [Neurocysticercosis. II. Evaluation of treatment with praziquantel]. ( Takayanagui, OM, 1990) |
| " We describe a case of disseminated muscular cysticercosis followed by myositis (fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci) induced by praziquantel therapy, an event not described previously." | 7.70 | Disseminated muscular cysticercosis with myositis induced by praziquantel therapy. ( Chimelli, L; Takayanagui, OM, 1998) |
| "Praziquantel (PZQ) is the drug of choice in the treatment of neurocysticercosis (NC), a parasitic disease caused by Taenia solium larvae." | 7.69 | Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel. ( Cuevas, C; Flisser, A; Madrazo, I; Montero, R; Ostrosky-Wegman, P, 1994) |
| "In a prospective study, 17 Brazilian patients with parenchymatous neurocysticercosis were monitored for a period of 12 months after treatment with praziquantel." | 7.69 | Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. ( Bedaque, EA; Feldmeier, H; Jansen-Rosseck, R; Kremsner, P; Martins, AR; Mühlschlegel, F; Pedretti, L; Rolfs, A; Schulte, G; Tamburus, WM, 1995) |
| "We report a patient with cerebral cysticercosis treated with praziquantel." | 7.69 | [Cerebral cysticercosis treated with praziquantel--a case report]. ( Inaba, M; Shimamoto, Y; Shimazaki, K; Shinoda, J; Sugiyama, E; Yamada, F, 1994) |
| "A patient had neurocysticercosis complicated by a seizure disorder requiring anticonvulsants; previous praziquantel therapy (50 mg/kg/day) had failed to eradicate the disease." | 7.69 | Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. ( Adubofour, KO; Bikin, DS; Dachman, WD; Johnson, CH; Mullin, PD; Winograd, M, 1994) |
| "A 59-year-old man with known neurocysticercosis developed a large cerebral infarction during praziquantel therapy." | 7.69 | Large cerebral infarction during praziquantel therapy in neurocysticercosis. ( Bang, OY; Choi, SA; Heo, JH; Kim, DI, 1997) |
| "Eight patients with neurocysticercosis treated with praziquantel (PZQ) were studied with serial MR imaging to demonstrate the early effects of the drug in brain lesions." | 7.68 | MR observations on the effects of praziquantel in neurocysticercosis. ( Gupta, AK; Jain, RK; Jena, A; Sanchetee, PC; Sapra, ML; Tripathi, R, 1992) |
| "In order to evaluate therapeutic efficacy of praziquantel against cysticercosis in pigs caused by the 'Taiwan Taenia' 16 small-ear miniature pigs were each fed with 10,000 or 30,000 eggs." | 7.68 | Evaluation of the efficacy of praziquantel against cysticercosis of a Taenia saginata-like tapeworm (Taiwan strain) in pigs. ( Fan, PC; Lin, CY, 1991) |
| "The neuropathological findings in a fatal case of neurocysticercosis treated with praziquantel are reported in this paper." | 7.68 | [Neurocysticercosis: neuropathologic study of a fatal case treated with praziquantel]. ( Andrade Filho, Ade S; de Queiroz, AC, 1991) |
| "The CSF and plasma concentrations of praziquantel (PZQ) were determined with high pressure liquid chromatography in 37 patients with cysticercosis of the central nervous system during a dosing regimen of PZQ 20 mg/kg p o q 8h for 3 days." | 7.68 | [Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel]. ( Jia, JY, 1991) |
| "A case of fourth ventricle cysticercosis treated with praziquantel is presented." | 7.68 | Clinical and radiographic response of fourth ventricle cysticercosis to praziquantel therapy. ( Botana, C; Fandiño, C; Fandiño, J; Gomez-Bueno, J; Rodriguez, D, 1991) |
| "Twenty seven patients with neurocysticercosis were treated with praziquantel in progressive doses reaching 50 mg/kg/day associated with dexamethasone for 21 days." | 7.68 | [Treatment of neurocysticercosis with praziquantel]. ( Costa, JM; Macedo, V; Mello, P; Souza, HA; Vianna, LG, 1990) |
| "Standard therapeutic regimens of praziquantel for neurocysticercosis use daily doses of 50 mg/kg for 15-21 days, with prolonged remission being achieved in 60-80% patients." | 7.68 | High-dose praziquantel for neurocysticercosis: efficacy and tolerability. ( Bittencourt, PR; Gorz, AM; Gracia, CM; Mazer, S; Oliveira, TV, 1990) |
| "Serum and CSF concentrations of praziquantel were analyzed in 8 patients with active neurocysticercosis aged 35 +/- 16 (mean +/- sd) years, in order to determine factors that may improve the therapeutic ratio." | 7.68 | High-dose praziquantel for neurocysticercosis: serum and CSF concentrations. ( Bittencourt, PR; Gorz, AM; Gracia, CM; Oliveira, TV, 1990) |
| "Albendazole or praziquantel were measured in plasma and cerebrospinal fluid (CSF) in 29 patients with neurocysticercosis." | 7.68 | Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. ( Hurtado, M; Jung, H; Medina, MT; Sanchez, M; Sotelo, J, 1990) |
| "Porcine Taenia solium cysticercosis, recognized as a model of the human disease, was used to analyze the effect of the anthelminthic drug praziquantel on hosts and parasites." | 7.68 | Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 1. Radiological, physiological and histopathological studies. ( Cohen, S; Collado, M; Correa, D; Fernandez, B; Flisser, A; Gonzalez, D; Madrazo, I; Rodriguez-Carbajal, J; Rodriguez-del-Rosal, E; Shkurovich, M, 1990) |
| "A patient with neurocysticercosis was successfully treated with praziquantel." | 7.67 | Successful treatment of neurocysticercosis with low-dose praziquantel. ( Pun, KK; Wong, WT, 1984) |
| "Twenty-six patients with cysticercosis of the brain parenchyma were treated with the antihelmintic agent praziquantel (50 mg per kilogram of body weight daily for 15 days)." | 7.67 | Therapy of parenchymal brain cysticercosis with praziquantel. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1984) |
| "A preliminary report of praziquantel (PZQ) treatment in 10 patients with cysticercosis in Vietnam is presented in this paper." | 7.67 | Preliminary report of praziquantel treatment of cysticercosis patients in Vietnam. ( Pham, HT; van Knapen, F, 1989) |
| "Thirty-three patients with confirmed cysticercosis, with or without cerebral involvement, were treated with praziquantel at a daily dose of 75 mg/kg tid for 3 to 10 consecutive days and evaluated for tolerance and therapeutic effects." | 7.67 | Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis. ( Joo, KH; Rim, HJ, 1989) |
| "The humoral immune response to treatment with praziquantel (PZQ) was studied in eight patients with parenchymal cerebral cysticercosis (CC)." | 7.67 | Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. ( Corona, T; Estañol, B; González-Barranco, D; Irigoyen, Mdel C; Juárez, H, 1989) |
| "A prospective open therapeutic study on volunteers with active neurocysticercosis using pyrazinoisoquinolone (Praziquantel) has shown that it is a safe and effective drug." | 7.67 | Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis. ( McKeown, CP; van Dellen, JR, 1988) |
| "Praziquantel and albendazole have been recently described as effective drugs for treating cysticercosis of the brain." | 7.67 | Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. ( Escobedo, F; Penagos, P; Sotelo, J, 1988) |
| "A patient who developed a cerebral infarct during the course of praziquantel therapy for neurocysticercosis is described." | 7.67 | Cerebral infarct precipitated by praziquantel in neurocysticercosis--a cautionary note. ( Huang, CY; Woo, E; Yu, YL, 1988) |
| "The selective use of praziquantel for the treatment of brain cysticercosis in human beings is described, based upon the results of clinical tests conducted during a 2 year period." | 7.67 | Selective indications for the use of praziquantel in the treatment of brain cysticercosis. ( Cruz-Segura, H; Mateos-Gomez, H; Vasconcelos, D; Zenteno Alanis, G, 1987) |
| "Praziquantel therapy has produced a much better prognosis in neurocysticercosis since 1980." | 7.67 | [CT follow-up of neurocysticercosis treated with praziquantel]. ( Aulich, A; Hammer, B; Schwartz, A, 1987) |
| "Two patients with cysticercosis received praziquantel (PZQ) 75 mg/kg/day orally together with 30 mg prednisone daily for 3 weeks." | 7.67 | Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis. ( Diekmann, HW; Groll, E; Mattie, H; Overbosch, D; Polderman, AM; van de Nes, JC, 1987) |
| "An infant with cerebral cysticercosis had marked clinical and radiographic improvement following treatment with praziquantel." | 7.67 | Cerebral cysticercosis: treatment with praziquantel. ( Kapadia, C; Norman, RM, 1986) |
| "The long-term results of praziquantel therapy in 141 patients with neurocysticercosis are presented." | 7.67 | Long-term results of praziquantel therapy in neurocysticercosis. ( Galindo-Virgen, S; Robles, C; Sedano, AM; Vargas-Tentori, N, 1987) |
| "Seven patients with chronic parenchymal brain cysticercosis were treated with albendazole for one month at daily doses of 15 mg/kg of body weight." | 7.67 | Albendazole therapy for neurocysticercosis. ( Escobedo, F; Penagos, P; Rodriguez, J; Sotelo, J, 1987) |
| "Cerebrospinal fluid (CSF) and serum samples of 10 patients with neurocysticercosis under treatment by praziquantel were studied in four occasions: before treatment (day 0) and during treatment on three occasions (days 1, 7 and 21)." | 7.67 | [ELISA (IgG and IgM) of the CSF and serum in neurocysticercosis under treatment with praziquantel: comparison with complement fixation reactions and immunofluorescence]. ( Costa, JM; Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1985) |
| "Thirty-five patients with active neurocysticercosis were treated with praziquantel and followed for 1 year after therapy." | 7.67 | Praziquantel in the treatment of neurocysticercosis: long-term follow-up. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1985) |
| "A patient with intravitreous cysticercosis was treated with the new anthelminthic drug, praziquantel." | 7.67 | Effect of praziquantel on intraocular cysticercosis: a case report. ( Kestelyn, P; Taelman, H, 1985) |
| "In 10 patients with neurocysticercosis (NC), an assessment was made of the praziquantel (PZQ) concentration in the cerebrospinal fluid (CSF), in non-deproteinized serum and in protein-free serum: before administration of the drug and the 1st." | 7.67 | Praziquantel in the cerebrospinal fluid in neurocysticercosis. ( de Rezende, GL; Diekmann, HW; Groll, E; Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1985) |
| "Twelve patients with cysticercosis including two cases of subcutaneous cysticercosis and ten cases of combined subcutaneous and, cerebral cysticercosis were treated with praziquantel 30 mg per kilogram of body weight daily in 3 divided doses for 10 days." | 7.67 | Treatment of cysticercosis with praziquantel at the Bangkok Hospital for Tropical Diseases. ( Bunnag, D; Vanijanonta, S, 1985) |
| "This paper summarizes the experience with Praziquantel, a new broad spectrum antihelmintic for the treatment of neurocysticercosis." | 7.66 | Medical management of neurocysticercosis with Praziquantel. ( Lawner, PM, 1983) |
| "A patient with cerebral cysticercosis had marked clinical and radiographic response to the administration of corticosteroids and praziquantel." | 7.66 | Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel. ( deGhetaldi, LD; Douville, AW; Norman, RM, 1983) |
| "Report of the observations of 40 patients suffering from neurocysticercosis, submitted to treatment by praziquantel, administered per os." | 7.66 | Administration of praziquantel in neurocysticercosis. ( Livramento, JA; Machado, LR; Nobrega, JP; Spina-França, A, 1982) |
| "Praziquantel treatment alone appeared to reduce the number of cysts, but did not decrease the viability of the remaining parasites." | 6.68 | Effective, single-dose treatment or porcine cysticercosis with oxfendazole. ( Bernal, T; Falcon, N; Garcia, HH; Gavidia, CM; Gilman, RH; Gonzales, AE; Lopez-Urbina, MT; Romero, M; Tsang, VC, 1996) |
| "Praziquantel (PZQ) has been commonly used to treat diverse parasitic infections for over thirty years." | 5.56 | Acute pancytopenia due to praziquantel treatment for cerebral cysticercosis: A rare case report. ( Deng, H; Fu, Y; Lai, J; Li, Q; Zhang, Y, 2020) |
| "Praziquantel was given to both children with dramatic improvement in clinical and CSF findings." | 5.30 | Acute cysticercal meningitis in children: response to praziquantel. ( Chiemchanya, S; Visudhiphan, P, 1997) |
| "Praziquantel has provided new hope." | 5.29 | Praziquantel therapy in neurocysticercosis. ( Agrawal, A; Singhal, KC; Srivastava, A; Srivastava, VK, 1993) |
| "Treatment with praziquantel resulted in the regression of only some of the cysts." | 5.28 | [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis]. ( Belec, L; Cohen, L; Pierrot-Deseilligny, C; Sanson, M; Signoret, JL, 1992) |
| "Praziquantel was given orally at a dosage of 45 mg/kg/day in 3 divided doses at 4-5 hour interval for 15 days." | 5.28 | The treatment of neurocysticercosis with praziquantel. ( Bunnag, D; Riganti, M; Vanijanonta, S, 1991) |
| "Swines with cysticercosis are a useful model to study human disease." | 5.28 | Swine cysticercosis treated with praziquantel, a short report. ( Cohen, S; Collado, MA; Fernandez, B; Fernandez, E; Flisser, A; Gonzalez, D; Madrazo, I; Plancarte, A; Rodriguez-Carbajal, J; Shkurovich, M, 1989) |
| "Praziquantel (PZQ) was administered to the patients at their admission to the study." | 5.28 | [Neurocysticercosis and praziquantel: long-term development in 100 patients]. ( Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1989) |
| "Treatment with praziquantel was given at 35 mg/day for 10 days, dexamethasone and carbamazepine were also given to reduce side effects." | 5.27 | Subcutaneous and cerebral cysticercosis treated with praziquantel. ( Conde, J; Cross, JH; Quimosing, EM, 1984) |
| "Treatment with praziquantel 50 mg/kg body weight daily for 14 days resulted in clinical and radiological improvement in the first patient, although she obviously still harbored a number of viable non-calcified parasites." | 5.27 | Cerebral cysticercosis: treatment with praziquantel. Report of two cases. ( Hess, K; Markwalder, K; Valavanis, A; Witassek, F, 1984) |
| "By treatment with praziquantel there was an essential improvement of seizure frequency and headaches." | 5.27 | [Cerebral cysticercosis. A report on the treatment with praziquantel]. ( Maier-Metz, F; Meyer-Wahl, JG, 1984) |
| "Praziquantel was evaluated for its larvicidal activity against naturally or experimentally induced Taenia hydatigena infections in sheep." | 5.27 | Efficacy of praziquantel against ovine cysticercosis caused by Taenia hydatigena. ( Gemmell, MA; Johnstone, PD, 1983) |
| "Praziquantel was administrated at daily dosage of 50 mg per kilogram of body weight, by oral route, distributed in three doses during 15 days." | 5.27 | Brain cysticercosis treated with praziquantel. Report of six cases. ( Abad, JM; Bollar, A; Fernańdez, J; García-Allut, A; Gelabert, M; Mostaza, A, 1988) |
| "Cerebral cysticercosis was diagnosed with computed tomography (CT) scan, showing signs of intracranial hypertension and cystic lesions, and was confirmed by serological investigation." | 5.27 | Cerebral cysticercosis successfully treated with praziquantel. ( Braconier, JH; Christensson, B, 1988) |
| "Praziquantel was ineffective and hazardous, causing some known and some previously unreported responses and reactions." | 5.27 | Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. ( Bhatt, M; Desai, S; Wadia, N, 1988) |
| "Neurocysticercosis is not uncommon in the immigrant population of large North American cities." | 5.27 | Neurocysticercosis: surgical and medical management with praziquantel. ( Farmer, JP; Knowles, KF; Leblanc, R; MacLean, JD; Melanson, D; Rouleau, G, 1986) |
| "Randomized clinical trial of treatment of patients with newly identified active neurocysticercosis with oral prednisolone alone (27 patients), praziquantel with prednisolone (54 patients), or albendazole with prednisolone (57 patients)." | 5.08 | Is the course of neurocysticercosis modified by treatment with antihelminthic agents? ( Carpio, A; Flores, C; Hauser, WA; León, P; Santillán, F, 1995) |
| "Plasma praziquantel concentrations were measured in 11 Thai patients with active neurocysticercosis (8 males and 3 females)." | 5.08 | Plasma concentrations of praziquantel during the therapy of neurocysticerosis with praziquantel, in the presence of antiepileptics and dexamethasone. ( Karbwang, J; Na-Bangchang, K; Vanijanonta, S, 1995) |
| "The purpose of this study was to determine the therapeutic efficacy of albendazole and praziquantel administration in the treatment of neurocysticercosis of the fourth ventricle." | 5.08 | Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. ( Correa, D; García, L; García-Torres, E; Madrazo, I; Proaño, JV, 1997) |
| "Praziquantel and albendazole have been recently described as effective drugs for treatment of intraparenchymal brain cysticercosis." | 5.07 | Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. ( Jardim, E; Takayanagui, OM, 1992) |
| "One hundred consecutive patients presenting with symptoms and signs of neurocysticercosis, confirmed by neuroimaging techniques were randomly assigned to treatment with either praziquantel 50 mg/kg/day for 15 days or albendazole 15 mg/kg/day for 30 days." | 5.07 | Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis. ( Cruz, I; Cruz, M; Horton, J, 1991) |
| "The efficacy of different regimens of therapy for parenchymal brain cysticercosis either with praziquantel (PZQ) or with albendazole (ALB) was compared in 114 patients." | 5.06 | Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. ( del Brutto, OH; Escobedo, F; Penagos, P; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1990) |
| "The results of the use of praziquantel (PZQ) for the etiologic treatment of neurocysticercosis (NC) are presented." | 5.06 | [Neurocysticercosis. II. Evaluation of treatment with praziquantel]. ( Takayanagui, OM, 1990) |
| " Neurocysticercosis was confirmed by repeated, significantly positive serology results and the dramatic response to praziquantel." | 4.79 | Distinctive serial magnetic resonance changes in a young woman with rapidly evolved neurocysticercosis, with positron emission tomography results. ( Izumi, Y; Nagakura, K; Nagayama, M; Shinohara, Y; Takagi, S, 1996) |
| "The study is based on 371 cerebrospinal fluid (CSF) samples and 324 serum samples from 40 patients with neurocysticercosis (NC) submitted to treatment with praziquantel." | 4.77 | [A cerebrospinal fluid syndrome in neurocysticercosis]. ( Livramento, JA, 1987) |
| "The current pharmacological treatment of neurocysticercosis is based on two drugs, praziquantel (PZQ) and albendazole; however, suboptimal efficacy has been documented." | 3.96 | Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies. ( Fernanda, GM; Francisca, PA; Guadalupe, PH; Helgi, JC; Iliana, GH; Javier, LF; Nelly, C; Susana, RI, 2020) |
| " After the patient was firstly administered the antiparasitic treatment of cysticercosis (praziquantel), he had status epilepticus." | 3.88 | [Treatment and nursing of a cysticercosis patient with multiple foci]. ( Ji-Guang, D; Yu-Hua, F, 2018) |
| " We describe a case of disseminated muscular cysticercosis followed by myositis (fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci) induced by praziquantel therapy, an event not described previously." | 3.70 | Disseminated muscular cysticercosis with myositis induced by praziquantel therapy. ( Chimelli, L; Takayanagui, OM, 1998) |
| "Praziquantel (PZQ) is the drug of choice in the treatment of neurocysticercosis (NC), a parasitic disease caused by Taenia solium larvae." | 3.69 | Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel. ( Cuevas, C; Flisser, A; Madrazo, I; Montero, R; Ostrosky-Wegman, P, 1994) |
| "In a prospective study, 17 Brazilian patients with parenchymatous neurocysticercosis were monitored for a period of 12 months after treatment with praziquantel." | 3.69 | Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. ( Bedaque, EA; Feldmeier, H; Jansen-Rosseck, R; Kremsner, P; Martins, AR; Mühlschlegel, F; Pedretti, L; Rolfs, A; Schulte, G; Tamburus, WM, 1995) |
| "We report a patient with cerebral cysticercosis treated with praziquantel." | 3.69 | [Cerebral cysticercosis treated with praziquantel--a case report]. ( Inaba, M; Shimamoto, Y; Shimazaki, K; Shinoda, J; Sugiyama, E; Yamada, F, 1994) |
| "A patient had neurocysticercosis complicated by a seizure disorder requiring anticonvulsants; previous praziquantel therapy (50 mg/kg/day) had failed to eradicate the disease." | 3.69 | Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. ( Adubofour, KO; Bikin, DS; Dachman, WD; Johnson, CH; Mullin, PD; Winograd, M, 1994) |
| "A 59-year-old man with known neurocysticercosis developed a large cerebral infarction during praziquantel therapy." | 3.69 | Large cerebral infarction during praziquantel therapy in neurocysticercosis. ( Bang, OY; Choi, SA; Heo, JH; Kim, DI, 1997) |
| "Two antigens of Cysticercus cellulosae, cystic fluid antigen (CFA) and the culture medium antigen (CMA), were used in Avidin-Biotin Peroxdase Complex-ELISA (ABC-ELISA) to detect IgG antibodies in 45 cases of cysticercosis treated with praziquantel." | 3.69 | A study on the culture medium antigens of Cystcercus cellulosae for detecting antibodies of cysticercosis by means of ABC-ELISA. ( Guo, H; Shi, DZ; Zhao, ZF, 1997) |
| "420 patients with cerebral cysticercosis, including 97 with intracranial hypertension, were treated by praziquantel 30-50 mg/kg a day, 7-10 days a course." | 3.68 | [A follow-up study of 420 cases of cerebral cysticercosis]. ( Zhu, S, 1992) |
| "Eight patients with neurocysticercosis treated with praziquantel (PZQ) were studied with serial MR imaging to demonstrate the early effects of the drug in brain lesions." | 3.68 | MR observations on the effects of praziquantel in neurocysticercosis. ( Gupta, AK; Jain, RK; Jena, A; Sanchetee, PC; Sapra, ML; Tripathi, R, 1992) |
| "In order to evaluate therapeutic efficacy of praziquantel against cysticercosis in pigs caused by the 'Taiwan Taenia' 16 small-ear miniature pigs were each fed with 10,000 or 30,000 eggs." | 3.68 | Evaluation of the efficacy of praziquantel against cysticercosis of a Taenia saginata-like tapeworm (Taiwan strain) in pigs. ( Fan, PC; Lin, CY, 1991) |
| "The neuropathological findings in a fatal case of neurocysticercosis treated with praziquantel are reported in this paper." | 3.68 | [Neurocysticercosis: neuropathologic study of a fatal case treated with praziquantel]. ( Andrade Filho, Ade S; de Queiroz, AC, 1991) |
| "The CSF and plasma concentrations of praziquantel (PZQ) were determined with high pressure liquid chromatography in 37 patients with cysticercosis of the central nervous system during a dosing regimen of PZQ 20 mg/kg p o q 8h for 3 days." | 3.68 | [Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel]. ( Jia, JY, 1991) |
| "A case of fourth ventricle cysticercosis treated with praziquantel is presented." | 3.68 | Clinical and radiographic response of fourth ventricle cysticercosis to praziquantel therapy. ( Botana, C; Fandiño, C; Fandiño, J; Gomez-Bueno, J; Rodriguez, D, 1991) |
| "Twenty seven patients with neurocysticercosis were treated with praziquantel in progressive doses reaching 50 mg/kg/day associated with dexamethasone for 21 days." | 3.68 | [Treatment of neurocysticercosis with praziquantel]. ( Costa, JM; Macedo, V; Mello, P; Souza, HA; Vianna, LG, 1990) |
| "Standard therapeutic regimens of praziquantel for neurocysticercosis use daily doses of 50 mg/kg for 15-21 days, with prolonged remission being achieved in 60-80% patients." | 3.68 | High-dose praziquantel for neurocysticercosis: efficacy and tolerability. ( Bittencourt, PR; Gorz, AM; Gracia, CM; Mazer, S; Oliveira, TV, 1990) |
| "Serum and CSF concentrations of praziquantel were analyzed in 8 patients with active neurocysticercosis aged 35 +/- 16 (mean +/- sd) years, in order to determine factors that may improve the therapeutic ratio." | 3.68 | High-dose praziquantel for neurocysticercosis: serum and CSF concentrations. ( Bittencourt, PR; Gorz, AM; Gracia, CM; Oliveira, TV, 1990) |
| "Albendazole or praziquantel were measured in plasma and cerebrospinal fluid (CSF) in 29 patients with neurocysticercosis." | 3.68 | Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. ( Hurtado, M; Jung, H; Medina, MT; Sanchez, M; Sotelo, J, 1990) |
| "Porcine Taenia solium cysticercosis, recognized as a model of the human disease, was used to analyze the effect of the anthelminthic drug praziquantel on hosts and parasites." | 3.68 | Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 1. Radiological, physiological and histopathological studies. ( Cohen, S; Collado, M; Correa, D; Fernandez, B; Flisser, A; Gonzalez, D; Madrazo, I; Rodriguez-Carbajal, J; Rodriguez-del-Rosal, E; Shkurovich, M, 1990) |
| "A patient with neurocysticercosis was successfully treated with praziquantel." | 3.67 | Successful treatment of neurocysticercosis with low-dose praziquantel. ( Pun, KK; Wong, WT, 1984) |
| "Twenty-six patients with cysticercosis of the brain parenchyma were treated with the antihelmintic agent praziquantel (50 mg per kilogram of body weight daily for 15 days)." | 3.67 | Therapy of parenchymal brain cysticercosis with praziquantel. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1984) |
| "A preliminary report of praziquantel (PZQ) treatment in 10 patients with cysticercosis in Vietnam is presented in this paper." | 3.67 | Preliminary report of praziquantel treatment of cysticercosis patients in Vietnam. ( Pham, HT; van Knapen, F, 1989) |
| "Thirty-three patients with confirmed cysticercosis, with or without cerebral involvement, were treated with praziquantel at a daily dose of 75 mg/kg tid for 3 to 10 consecutive days and evaluated for tolerance and therapeutic effects." | 3.67 | Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis. ( Joo, KH; Rim, HJ, 1989) |
| "The humoral immune response to treatment with praziquantel (PZQ) was studied in eight patients with parenchymal cerebral cysticercosis (CC)." | 3.67 | Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. ( Corona, T; Estañol, B; González-Barranco, D; Irigoyen, Mdel C; Juárez, H, 1989) |
| "Ten patients with cerebral cysticercosis seen between 1983 and 1986 were treated with praziquantel and in some cases by a ventriculoperitoneal shunt and/or surgical excision of cysts." | 3.67 | [Cerebral cysticercosis. 10 cases]. ( Botana, C; Fandiño, J; Gómez-Bueno, J; Pastor, A; Rodríguez, M; Viladrich, A, 1989) |
| "A large-scale study in Loja and El Oro Provinces, Ecuador, demonstrated that population-based treatment of human taeniasis with a low dose of praziquantel is feasible and effective for the short-term control of transmission of Taenia solium in hyperendemic areas." | 3.67 | Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. ( Cruz, M; Davis, A; Dixon, H; Pawlowski, ZS; Proano, J, 1989) |
| "A prospective open therapeutic study on volunteers with active neurocysticercosis using pyrazinoisoquinolone (Praziquantel) has shown that it is a safe and effective drug." | 3.67 | Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis. ( McKeown, CP; van Dellen, JR, 1988) |
| "Praziquantel and albendazole have been recently described as effective drugs for treating cysticercosis of the brain." | 3.67 | Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. ( Escobedo, F; Penagos, P; Sotelo, J, 1988) |
| "A patient who developed a cerebral infarct during the course of praziquantel therapy for neurocysticercosis is described." | 3.67 | Cerebral infarct precipitated by praziquantel in neurocysticercosis--a cautionary note. ( Huang, CY; Woo, E; Yu, YL, 1988) |
| "The selective use of praziquantel for the treatment of brain cysticercosis in human beings is described, based upon the results of clinical tests conducted during a 2 year period." | 3.67 | Selective indications for the use of praziquantel in the treatment of brain cysticercosis. ( Cruz-Segura, H; Mateos-Gomez, H; Vasconcelos, D; Zenteno Alanis, G, 1987) |
| "Praziquantel therapy has produced a much better prognosis in neurocysticercosis since 1980." | 3.67 | [CT follow-up of neurocysticercosis treated with praziquantel]. ( Aulich, A; Hammer, B; Schwartz, A, 1987) |
| "Treatment with praziquantel for neurocysticercosis frequently induces adverse reactions due to acute destruction of parasites; these reactions are suppressed by dexamethasone therapy." | 3.67 | Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. ( Jung, H; Sotelo, J; Vazquez, ML, 1987) |
| "Two patients with cysticercosis received praziquantel (PZQ) 75 mg/kg/day orally together with 30 mg prednisone daily for 3 weeks." | 3.67 | Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis. ( Diekmann, HW; Groll, E; Mattie, H; Overbosch, D; Polderman, AM; van de Nes, JC, 1987) |
| "An infant with cerebral cysticercosis had marked clinical and radiographic improvement following treatment with praziquantel." | 3.67 | Cerebral cysticercosis: treatment with praziquantel. ( Kapadia, C; Norman, RM, 1986) |
| "The long-term results of praziquantel therapy in 141 patients with neurocysticercosis are presented." | 3.67 | Long-term results of praziquantel therapy in neurocysticercosis. ( Galindo-Virgen, S; Robles, C; Sedano, AM; Vargas-Tentori, N, 1987) |
| "Seven patients with chronic parenchymal brain cysticercosis were treated with albendazole for one month at daily doses of 15 mg/kg of body weight." | 3.67 | Albendazole therapy for neurocysticercosis. ( Escobedo, F; Penagos, P; Rodriguez, J; Sotelo, J, 1987) |
| "Cerebrospinal fluid (CSF) and serum samples of 10 patients with neurocysticercosis under treatment by praziquantel were studied in four occasions: before treatment (day 0) and during treatment on three occasions (days 1, 7 and 21)." | 3.67 | [ELISA (IgG and IgM) of the CSF and serum in neurocysticercosis under treatment with praziquantel: comparison with complement fixation reactions and immunofluorescence]. ( Costa, JM; Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1985) |
| "Thirty-five patients with active neurocysticercosis were treated with praziquantel and followed for 1 year after therapy." | 3.67 | Praziquantel in the treatment of neurocysticercosis: long-term follow-up. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1985) |
| "A patient with intravitreous cysticercosis was treated with the new anthelminthic drug, praziquantel." | 3.67 | Effect of praziquantel on intraocular cysticercosis: a case report. ( Kestelyn, P; Taelman, H, 1985) |
| "In 10 patients with neurocysticercosis (NC), an assessment was made of the praziquantel (PZQ) concentration in the cerebrospinal fluid (CSF), in non-deproteinized serum and in protein-free serum: before administration of the drug and the 1st." | 3.67 | Praziquantel in the cerebrospinal fluid in neurocysticercosis. ( de Rezende, GL; Diekmann, HW; Groll, E; Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1985) |
| "Twelve patients with cysticercosis including two cases of subcutaneous cysticercosis and ten cases of combined subcutaneous and, cerebral cysticercosis were treated with praziquantel 30 mg per kilogram of body weight daily in 3 divided doses for 10 days." | 3.67 | Treatment of cysticercosis with praziquantel at the Bangkok Hospital for Tropical Diseases. ( Bunnag, D; Vanijanonta, S, 1985) |
| "This paper summarizes the experience with Praziquantel, a new broad spectrum antihelmintic for the treatment of neurocysticercosis." | 3.66 | Medical management of neurocysticercosis with Praziquantel. ( Lawner, PM, 1983) |
| "A patient with cerebral cysticercosis had marked clinical and radiographic response to the administration of corticosteroids and praziquantel." | 3.66 | Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel. ( deGhetaldi, LD; Douville, AW; Norman, RM, 1983) |
| "Report of the observations of 40 patients suffering from neurocysticercosis, submitted to treatment by praziquantel, administered per os." | 3.66 | Administration of praziquantel in neurocysticercosis. ( Livramento, JA; Machado, LR; Nobrega, JP; Spina-França, A, 1982) |
| "Praziquantel treatment alone appeared to reduce the number of cysts, but did not decrease the viability of the remaining parasites." | 2.68 | Effective, single-dose treatment or porcine cysticercosis with oxfendazole. ( Bernal, T; Falcon, N; Garcia, HH; Gavidia, CM; Gilman, RH; Gonzales, AE; Lopez-Urbina, MT; Romero, M; Tsang, VC, 1996) |
| "Praziquantel was chosen for treatment of taeniasis and albendazole for treatment of cysticercosis." | 2.50 | Current status of taeniasis and cysticercosis in Vietnam. ( Eom, KS; Le, TH; Lien, PT; Van De, N, 2014) |
| "Orbital cysticercosis is secondary to an infestation by cysticercus cellulosae, the larval form of Taenia solium." | 2.47 | Orbital cysticercosis, case report and review. ( Bremner, FD; Elgohary, M; Ziaei, M, 2011) |
| "Albendazole has been found to be the best drug for treating cysticercosis though it does not appear to be totally effective for curing cerebral cysts." | 2.42 | Current status of cysticercosis in Vietnam. ( Cam, PD; Cong, le D; Dalsgaard, A; De, NV; Doanh, NQ; Dorny, P; Dung, TV; Willingham, AL, 2003) |
| "Praziquantel is a synthetic drug with a remarkable activity against parasites, particularly treamatodes and cestodes." | 2.40 | Genotoxic activity of praziquantel. ( Montero, R; Ostrosky, P, 1997) |
| " Peak concentration in serum is reached after 1 to 2 hours and the elimination half-life is between 1 and 3 hours." | 2.40 | Pharmacokinetic optimisation of the treatment of neurocysticercosis. ( Jung, H; Sotelo, J, 1998) |
| "MR-tomography showed an internal hydrocephalus and multiple contrast enhancing parenchymal cysts." | 2.40 | [Neurocysticercosis. Current review of the literature based on a long-term study of 2 clinically distinct German cases]. ( Delcker, A; Häussermann, P; Koeppen, S; Wiegand, F, 1999) |
| "Neurocysticercosis is the most important parasitic infection of the nervous system in countries of the third world." | 2.38 | Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy. ( Overbosch, D, 1992) |
| "Treatment with praziquantel or albendazole has hastened the disappearance of the cysts on computed tomography and improved clinical symptoms." | 2.38 | Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. ( Davis, LE; Kornfeld, M, 1991) |
| "Praziquantel was not used." | 2.37 | Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. ( Crawford, TO; Mitchell, WG, 1988) |
| "Subarachnoid cysticercosis is a type of extra-parenchymal infection in which the prevalence is not known and racemose NC with cerebellar involvement has been rarely reported." | 1.62 | Subarachnoid racemose neurocysticercosis with cerebellar involvement: an old friend in an infrequent location? ( Calderon-Vargas, CM; Montejo-Coy, JA; Parra-Cárdenas, DM; Severiche-Bueno, DF; Vargas-Cuervo, MT, 2021) |
| "Disseminated cysticercosis is an unusual opportunistic infection which can present as subcutaneous nodules without other typical cysticercosis symptoms." | 1.56 | Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report. ( Bacha, JM; Campbell, LR; El-Mallawany, NK; Kovarik, CL; McCormick, DW; Slone, JS, 2020) |
| "Praziquantel (PZQ) has been commonly used to treat diverse parasitic infections for over thirty years." | 1.56 | Acute pancytopenia due to praziquantel treatment for cerebral cysticercosis: A rare case report. ( Deng, H; Fu, Y; Lai, J; Li, Q; Zhang, Y, 2020) |
| "Taenia solium cysticercosis is a common parasitic infection of humans and pigs." | 1.42 | Successful Antiparasitic Treatment for Cysticercosis is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model. ( Bustos, JA; Castillo, Y; Dorny, P; Gabriël, S; Garcia, HH; Gilman, RH; Gonzalez, AE; Praet, N; Rodriguez, S; Zimic, M, 2015) |
| " The aim of this study was to evaluate alterations in glycolysis, the tricarboxylic acid cycle and glucose concentrations caused by low dosage treatments of the hosts with albendazole and praziquantel." | 1.38 | Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci. ( Bezerra, JC; Costa, TL; de Souza Lino, R; Fraga, CM; Vinaud, MC, 2012) |
| "Cysticercosis is a disease caused by the hydatid of the porcine tapeworm (cysticercus)." | 1.32 | [Cysticercosis as a rare cause of a tumor of the tongue]. ( Gocht, A; Metternich, FU; Roth, B, 2003) |
| "Cysticercosis is an helminthic disease which is usually observed in endemic areas or in immigrants coming from these areas." | 1.32 | [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller]. ( Bricaire, E; Caumes, E; Chemali, N; Danis, M; Epelboin, L; Klement, E, 2004) |
| "Praziquantel was given to both children with dramatic improvement in clinical and CSF findings." | 1.30 | Acute cysticercal meningitis in children: response to praziquantel. ( Chiemchanya, S; Visudhiphan, P, 1997) |
| "Human cysticercosis is secondary to an infestation by cysticercus cellulosae, the larval form of Taenia solium." | 1.30 | Orbital cysticercosis. ( Lemke, BN; Sekhar, GC, 1997) |
| "Cysticercosis is the most common parasitic disease affecting the central nervous system." | 1.29 | Subarachnoid neurocysticercosis with occlusion of the major intracranial arteries: case report. ( Levy, AS; Lillehei, KO; Rubinstein, D; Stears, JC, 1995) |
| "Cysticercosis is discussed as a possible differential diagnosis." | 1.29 | Meningeal irritation: possible manifestation of cerebral Echinococcus infestation. ( Bakke, SJ; Dietrichs, E; van Knapen, F, 1994) |
| "Praziquantel has provided new hope." | 1.29 | Praziquantel therapy in neurocysticercosis. ( Agrawal, A; Singhal, KC; Srivastava, A; Srivastava, VK, 1993) |
| "After medical treatment of neurocysticercosis, there is usually remission or marked improvement in the associated seizure disorder." | 1.28 | The course of seizures after treatment for cerebral cysticercosis. ( Sotelo, J; Vazquez, V, 1992) |
| "Cysticercosis is a parasitic disease endemic in several developing countries where people consume raw or insufficiently cooked pork." | 1.28 | You drive me crazy: a case report of acute psychosis and neurocysticercosis. ( Milette, PC; Shriqui, CL, 1992) |
| "Treatment with praziquantel resulted in the regression of only some of the cysts." | 1.28 | [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis]. ( Belec, L; Cohen, L; Pierrot-Deseilligny, C; Sanson, M; Signoret, JL, 1992) |
| "A 33-year-old patient with AIDS, and a history of episodes of Pneumocystis carinii pneumonia and cerebral toxoplasmosis, developed a subcutaneous paravertebral infiltrate, which at first resembled a haematoma." | 1.28 | [Taenia crassiceps infection in AIDS]. ( Gross, U; Joeres, R; Klinker, H; Landwehr, P; Müller, J; Richter, E; Schmidt-Rotte, H; Tintelnot, K, 1992) |
| "Praziquantel was given orally at a dosage of 45 mg/kg/day in 3 divided doses at 4-5 hour interval for 15 days." | 1.28 | The treatment of neurocysticercosis with praziquantel. ( Bunnag, D; Riganti, M; Vanijanonta, S, 1991) |
| " In this study, 40 patients with Taenia saginata and 15 with Hymenolepis nana were treated by one single oral dose of Praziquantel, at the dosage of 10 mg/kg/day and 20 mg/kg/day respectively." | 1.28 | Successful treatment of Taenia saginata and Hymenolepis nana by single oral dose of praziquantel. ( Bouree, P, 1991) |
| "Neurocysticercosis has not to our knowledge been previously reported to have presented with myoclonus." | 1.28 | Myoclonus: a manifestation of neurocysticercosis. ( Chowdhury, V; Gulati, P; Puri, V, 1991) |
| "Neurocysticercosis is an uncommon, and under-recognized condition in Australia." | 1.28 | Neurocysticercosis: an under-recognized cause of neurological problems. ( Collignon, PJ; Crimmins, D; Danta, G; Dwyer, D, 1990) |
| " Treatment using praziquantel a single dosage of 10 mg/kg body weight expelled the worm including the scolex." | 1.28 | Observations on self-induced Taenia saginata infection. ( Tesfa-Yohannes, TM, 1990) |
| "900 persons received treatment against taeniasis." | 1.28 | A programme to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village. ( de Aluja, AS; Keilbach, NM; Sarti-Gutierrez, E, 1989) |
| "Swines with cysticercosis are a useful model to study human disease." | 1.28 | Swine cysticercosis treated with praziquantel, a short report. ( Cohen, S; Collado, MA; Fernandez, B; Fernandez, E; Flisser, A; Gonzalez, D; Madrazo, I; Plancarte, A; Rodriguez-Carbajal, J; Shkurovich, M, 1989) |
| "Neurocysticercosis is a very rare disease in Central Europe." | 1.28 | [Acute meningitis with cerebrospinal fluid eosinophilia: neurocysticercosis]. ( Abel, W; Flentje, B; Hackebeil, C; Lippmann, P; Matschke, HJ, 1989) |
| "Praziquantel (PZQ) was administered to the patients at their admission to the study." | 1.28 | [Neurocysticercosis and praziquantel: long-term development in 100 patients]. ( Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1989) |
| "Treatment with Praziquantel was uneffective." | 1.27 | [Pure spinal cysticercosis. Note on the cerebrospinal fluid]. ( Baulac, M; Carydakis, C; Laplane, D; Philippon, J; Schuller, E, 1984) |
| "Treatment with praziquantel was given at 35 mg/day for 10 days, dexamethasone and carbamazepine were also given to reduce side effects." | 1.27 | Subcutaneous and cerebral cysticercosis treated with praziquantel. ( Conde, J; Cross, JH; Quimosing, EM, 1984) |
| "Treatment with praziquantel 50 mg/kg body weight daily for 14 days resulted in clinical and radiological improvement in the first patient, although she obviously still harbored a number of viable non-calcified parasites." | 1.27 | Cerebral cysticercosis: treatment with praziquantel. Report of two cases. ( Hess, K; Markwalder, K; Valavanis, A; Witassek, F, 1984) |
| "By treatment with praziquantel there was an essential improvement of seizure frequency and headaches." | 1.27 | [Cerebral cysticercosis. A report on the treatment with praziquantel]. ( Maier-Metz, F; Meyer-Wahl, JG, 1984) |
| "Praziquantel was evaluated for its larvicidal activity against naturally or experimentally induced Taenia hydatigena infections in sheep." | 1.27 | Efficacy of praziquantel against ovine cysticercosis caused by Taenia hydatigena. ( Gemmell, MA; Johnstone, PD, 1983) |
| "Praziquantel recently has been approved in the United States for use against a broad range of trematodes and cestodes." | 1.27 | Praziquantel: a major advance in anthelminthic therapy. ( Guerrant, RL; Pearson, RD, 1983) |
| "Cysticercosis is the most common parasite affecting the central nervous system and is a serious health problem in many parts of the world." | 1.27 | Cysticercosis: etiology and nursing care. ( Minnick, A, 1986) |
| "Praziquantel was administrated at daily dosage of 50 mg per kilogram of body weight, by oral route, distributed in three doses during 15 days." | 1.27 | Brain cysticercosis treated with praziquantel. Report of six cases. ( Abad, JM; Bollar, A; Fernańdez, J; García-Allut, A; Gelabert, M; Mostaza, A, 1988) |
| "Cerebral cysticercosis was diagnosed with computed tomography (CT) scan, showing signs of intracranial hypertension and cystic lesions, and was confirmed by serological investigation." | 1.27 | Cerebral cysticercosis successfully treated with praziquantel. ( Braconier, JH; Christensson, B, 1988) |
| "Praziquantel was ineffective and hazardous, causing some known and some previously unreported responses and reactions." | 1.27 | Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. ( Bhatt, M; Desai, S; Wadia, N, 1988) |
| "Treatment with Praziquantel reduced the patient's intellectual deterioration, but hydrocephalus developed." | 1.27 | Severe dementia associated with neurocysticercosis. ( Ardila, A; Penagos, B; Rosselli, A; Rosselli, M, 1988) |
| "Cerebral cysticercosis is becoming more common in Australia as the immigrant population from areas of endemic disease increases." | 1.27 | Cerebral cysticercosis: a case report with particular reference to recent advances in diagnosis and treatment. ( Lyall, I; Nolan, C; Pascoe, M; Saines, N, 1987) |
| "Neurocysticercosis is not uncommon in the immigrant population of large North American cities." | 1.27 | Neurocysticercosis: surgical and medical management with praziquantel. ( Farmer, JP; Knowles, KF; Leblanc, R; MacLean, JD; Melanson, D; Rouleau, G, 1986) |
| "Praziquantel was given without evident benefit; this therapeutic response is discussed in relation to the clinical and radiological findings." | 1.27 | Neurocysticercosis: clinical and therapeutic considerations. Review of Italian literature. ( Boiardi, A; Bussone, G; Campi, A; Frediani, F; La Mantia, L; Lamperti, E; Salmaggi, A; Sinatra, MG, 1986) |
| "The use of praziquantel in the treatment of cysticercosis is a major step towards eradicating the disease, but to be effective treatment must take cognizance of reinfection, the allergic reaction caused by the dying parasites, and the possible need for repeated courses of treatment." | 1.27 | Neurocysticercosis--a comprehensive approach to medical treatment. ( Joubert, J; Joubert, MJ; Lombaard, CM, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 131 (44.86) | 18.7374 |
| 1990's | 128 (43.84) | 18.2507 |
| 2000's | 12 (4.11) | 29.6817 |
| 2010's | 13 (4.45) | 24.3611 |
| 2020's | 8 (2.74) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, HY | 1 |
| Wang, GX | 1 |
| Xing, YY | 1 |
| Xie, MR | 1 |
| Francisca, PA | 1 |
| Javier, LF | 1 |
| Guadalupe, PH | 1 |
| Fernanda, GM | 1 |
| Nelly, C | 1 |
| Helgi, JC | 1 |
| Iliana, GH | 1 |
| Susana, RI | 1 |
| Haby, MM | 1 |
| Sosa Leon, LA | 1 |
| Luciañez, A | 1 |
| Nicholls, RS | 1 |
| Reveiz, L | 1 |
| Donadeu, M | 1 |
| McCormick, DW | 1 |
| Bacha, JM | 1 |
| El-Mallawany, NK | 1 |
| Kovarik, CL | 1 |
| Slone, JS | 1 |
| Campbell, LR | 1 |
| Zhang, Y | 1 |
| Fu, Y | 1 |
| Deng, H | 1 |
| Li, Q | 1 |
| Lai, J | 1 |
| White, AC | 2 |
| O'Neal, S | 1 |
| Winkler, A | 1 |
| Abraham, A | 1 |
| Carabin, H | 1 |
| Parra-Cárdenas, DM | 1 |
| Vargas-Cuervo, MT | 1 |
| Montejo-Coy, JA | 1 |
| Calderon-Vargas, CM | 1 |
| Severiche-Bueno, DF | 1 |
| Heller, T | 1 |
| Wallrauch, C | 1 |
| Kaminstein, D | 1 |
| Phiri, S | 1 |
| Yu-Hua, F | 1 |
| Ji-Guang, D | 1 |
| Hobbs, EC | 1 |
| Mwape, KE | 1 |
| Phiri, AM | 1 |
| Mambwe, M | 1 |
| Mambo, R | 1 |
| Thys, S | 1 |
| Zulu, G | 1 |
| Chembensofu, M | 1 |
| Trevisan, C | 1 |
| Van Damme, I | 1 |
| Phiri, IK | 1 |
| Devleesschauwer, B | 1 |
| Ketzis, J | 1 |
| Dorny, P | 3 |
| Willingham, AL | 2 |
| Gabriël, S | 2 |
| Flammer Anikpeh, Y | 1 |
| Grimm, F | 1 |
| Lindenblatt, N | 1 |
| Zinkernagel, A | 1 |
| Van De, N | 1 |
| Le, TH | 1 |
| Lien, PT | 1 |
| Eom, KS | 1 |
| Scala, A | 1 |
| Urrai, G | 1 |
| Varcasia, A | 1 |
| Nicolussi, P | 1 |
| Mulas, M | 1 |
| Goddi, L | 1 |
| Pipia, AP | 1 |
| Sanna, G | 1 |
| Genchi, M | 1 |
| Bandino, E | 1 |
| Palomares-Alonso, F | 1 |
| Palencia Hernández, G | 1 |
| Rojas-Tomé, IS | 1 |
| Jung-Cook, H | 1 |
| Pinzón-Estrada, E | 1 |
| Gonzalez, AE | 1 |
| Bustos, JA | 1 |
| Garcia, HH | 3 |
| Rodriguez, S | 1 |
| Zimic, M | 1 |
| Castillo, Y | 1 |
| Praet, N | 1 |
| Gilman, RH | 2 |
| Silva, LD | 1 |
| Arrúa, EC | 1 |
| Pereira, DA | 1 |
| Fraga, CM | 3 |
| Costa, TL | 3 |
| Hemphill, A | 1 |
| Salomon, CJ | 1 |
| Vinaud, MC | 3 |
| Howell, J | 1 |
| Brown, G | 1 |
| Ziaei, M | 1 |
| Elgohary, M | 1 |
| Bremner, FD | 1 |
| Bezerra, JC | 2 |
| de Souza Lino, R | 1 |
| Yanagida, T | 1 |
| Sako, Y | 2 |
| Nakao, M | 1 |
| Nakaya, K | 1 |
| Ito, A | 2 |
| Wandra, T | 1 |
| Sudewi, AA | 1 |
| Swastika, IK | 1 |
| Sutisna, P | 1 |
| Dharmawan, NS | 1 |
| Yulfi, H | 1 |
| Darlan, DM | 1 |
| Kapti, IN | 1 |
| Samaan, G | 1 |
| Sato, MO | 1 |
| Okamoto, M | 1 |
| de Souza Lino Junior, R | 1 |
| Wolf, A | 1 |
| Rovira, AR | 1 |
| Miller, KL | 1 |
| Widmer, WR | 1 |
| Rabenjamina, FR | 1 |
| Ranaivoravo, J | 1 |
| Raholimina, V | 1 |
| Ramialiharisoa, A | 1 |
| Nash, TE | 2 |
| Sarti, E | 2 |
| Rajshekhar, V | 1 |
| Roth, B | 1 |
| Gocht, A | 1 |
| Metternich, FU | 1 |
| De, NV | 1 |
| Doanh, NQ | 1 |
| Cong, le D | 1 |
| Dung, TV | 1 |
| Cam, PD | 1 |
| Dalsgaard, A | 1 |
| Adegbehingbe, BO | 1 |
| Soetan, EO | 1 |
| Adeoye, AO | 1 |
| Palomares, F | 1 |
| Palencia, G | 1 |
| Pérez, R | 1 |
| González-Esquivel, D | 1 |
| Castro, N | 1 |
| Cook, HJ | 1 |
| Duong, TH | 2 |
| Monegierdu Sorbier, C | 1 |
| Bailly, ER | 1 |
| Guillou-Garnier, MF | 1 |
| Fetissof, F | 1 |
| Richard-Lenoble, D | 1 |
| Schweizer, G | 1 |
| Grünenfelder, F | 1 |
| Sydler, T | 1 |
| Rademacher, N | 1 |
| Braun, U | 1 |
| Deplazes, P | 1 |
| Epelboin, L | 1 |
| Klement, E | 1 |
| Chemali, N | 1 |
| Danis, M | 1 |
| Bricaire, E | 1 |
| Caumes, E | 1 |
| Zhu, DY | 4 |
| Sun, HL | 1 |
| Xu, WC | 4 |
| Zeng, MQ | 1 |
| Chen, LG | 1 |
| Liu, GY | 1 |
| Qian, YD | 2 |
| Bao, YF | 1 |
| Qu, JQ | 1 |
| Grisolia, JS | 1 |
| Neva, FA | 1 |
| Baas, H | 1 |
| Schneider, E | 2 |
| Grau, H | 1 |
| Prange, H | 1 |
| Gräfin Vitzthum, H | 1 |
| Ma, YX | 1 |
| Liu, YH | 1 |
| Bell, DR | 1 |
| Colli, BO | 1 |
| Martelli, N | 1 |
| Assirati Júnior, JA | 1 |
| Machado, HR | 1 |
| Guerreiro, NE | 1 |
| Belluci, A | 1 |
| Gomez, JG | 1 |
| Sanchez, E | 1 |
| Pardo, R | 1 |
| Biller, J | 1 |
| Azar-Kia, B | 1 |
| O'Keefe, P | 1 |
| Carydakis, C | 1 |
| Baulac, M | 1 |
| Laplane, D | 1 |
| Schuller, E | 1 |
| Philippon, J | 1 |
| Quimosing, EM | 1 |
| Conde, J | 1 |
| Cross, JH | 1 |
| Pun, KK | 1 |
| Wong, WT | 1 |
| Chen, MG | 1 |
| Harrison, LJ | 1 |
| Gallie, GJ | 2 |
| Sewell, MM | 2 |
| Chen, WK | 2 |
| Santos, R | 1 |
| Chavarria, M | 2 |
| Aguirre, AE | 1 |
| Lawner, PM | 1 |
| Sotelo, J | 15 |
| Escobedo, F | 5 |
| Rodriguez-Carbajal, J | 5 |
| Torres, B | 3 |
| Rubio-Donnadieu, F | 3 |
| Markwalder, K | 1 |
| Hess, K | 1 |
| Valavanis, A | 1 |
| Witassek, F | 1 |
| Meyer-Wahl, JG | 1 |
| Maier-Metz, F | 1 |
| Friedman, J | 1 |
| Mates, S | 1 |
| Gemmell, MA | 1 |
| Johnstone, PD | 1 |
| deGhetaldi, LD | 1 |
| Norman, RM | 2 |
| Douville, AW | 1 |
| Pearson, RD | 2 |
| Guerrant, RL | 1 |
| Lombardo, L | 1 |
| Vasconcelos, D | 3 |
| Cruz-Segura, H | 2 |
| Spina-França, A | 6 |
| Nobrega, JP | 6 |
| Livramento, JA | 6 |
| Machado, LR | 5 |
| Thomas, H | 1 |
| Andrews, P | 1 |
| Mehlhorn, H | 1 |
| Botero, D | 2 |
| Castaño, S | 1 |
| Blazek, K | 1 |
| Schramlová, J | 1 |
| Arkhipova, NS | 1 |
| Nisenbaum, JA | 1 |
| Xu, ZY | 1 |
| Robles, C | 3 |
| Bessonov, AS | 1 |
| Uspenskiĭ, AV | 1 |
| Komarov, IuB | 1 |
| Azimov, ShA | 1 |
| Alferova, MV | 1 |
| Montero, R | 3 |
| Flisser, A | 7 |
| Madrazo, I | 5 |
| Cuevas, C | 1 |
| Ostrosky-Wegman, P | 2 |
| Carpio, A | 3 |
| Santillán, F | 1 |
| León, P | 1 |
| Flores, C | 1 |
| Hauser, WA | 2 |
| Martinez, HR | 1 |
| Rangel-Guerra, R | 1 |
| Arredondo-Estrada, JH | 1 |
| Marfil, A | 1 |
| Onofre, J | 1 |
| Levy, AS | 1 |
| Lillehei, KO | 1 |
| Rubinstein, D | 1 |
| Stears, JC | 1 |
| Baumeister, S | 1 |
| Schuh, C | 1 |
| Dennis, RD | 1 |
| Walther, M | 3 |
| Pfister, K | 1 |
| Geyer, E | 1 |
| Sickel, JZ | 1 |
| Fultz, PJ | 1 |
| Penwarden, B | 1 |
| Laczin, J | 1 |
| La Mantia, L | 2 |
| Costa, A | 1 |
| Eoli, M | 1 |
| Savoiardo, M | 1 |
| Waldvogel, F | 1 |
| Körner, F | 1 |
| Terrier, F | 1 |
| del Brutto, OH | 6 |
| Avodé, DG | 1 |
| Bouteille, B | 1 |
| Avimadje, M | 1 |
| Adjien, C | 1 |
| Agarwal, AK | 1 |
| Dudeja, RK | 1 |
| Chandra, S | 1 |
| Dietrichs, E | 2 |
| van Knapen, F | 2 |
| Bakke, SJ | 2 |
| Diederich, C | 1 |
| Keuchel, M | 1 |
| Burchard, GD | 1 |
| Gilbert, P | 1 |
| Dietrich, M | 1 |
| Chagnon, A | 2 |
| Galzin, M | 1 |
| de Jaureguiberry, JP | 1 |
| Boyer, B | 1 |
| Paris, JF | 2 |
| Marlier, S | 1 |
| Carli, P | 2 |
| Rolfs, A | 1 |
| Mühlschlegel, F | 1 |
| Jansen-Rosseck, R | 1 |
| Martins, AR | 1 |
| Bedaque, EA | 1 |
| Tamburus, WM | 1 |
| Pedretti, L | 1 |
| Schulte, G | 1 |
| Feldmeier, H | 1 |
| Kremsner, P | 1 |
| Mafojane, NA | 1 |
| Tyssvang, T | 1 |
| Aanonsen, NO | 1 |
| Skullerud, K | 1 |
| Shimamoto, Y | 1 |
| Sugiyama, E | 1 |
| Inaba, M | 1 |
| Shinoda, J | 1 |
| Shimazaki, K | 1 |
| Yamada, F | 1 |
| Plancarte, A | 4 |
| Schantz, P | 1 |
| Allan, J | 1 |
| Craig, P | 1 |
| Monteiro, L | 1 |
| Almeida-Pinto, J | 1 |
| Stocker, A | 1 |
| Sampaio-Silva, M | 1 |
| Dachman, WD | 1 |
| Adubofour, KO | 1 |
| Bikin, DS | 1 |
| Johnson, CH | 1 |
| Mullin, PD | 1 |
| Winograd, M | 1 |
| Green, LE | 1 |
| Berriatua, E | 1 |
| Morgan, KL | 1 |
| Tanowitz, HB | 1 |
| Weiss, LM | 1 |
| Wittner, M | 1 |
| Roman, GC | 1 |
| Srivastava, VK | 1 |
| Singhal, KC | 1 |
| Srivastava, A | 1 |
| Agrawal, A | 1 |
| Dumois, JA | 1 |
| Whitman, BW | 1 |
| Vezina, LG | 1 |
| Ohnishi, K | 1 |
| Murata, M | 1 |
| Nakane, M | 1 |
| Takemura, N | 1 |
| Tsuchida, T | 1 |
| Nakamura, T | 1 |
| Mukherjee, A | 1 |
| Roy, T | 1 |
| Mukherjee, S | 1 |
| Basu, N | 1 |
| Duttamunshi, A | 1 |
| Shandera, WX | 1 |
| Chen, JC | 1 |
| Diaz, P | 1 |
| Armstrong, R | 1 |
| St Geme, JW | 1 |
| Maldonado, YA | 1 |
| Enzmann, D | 1 |
| Hotez, PJ | 1 |
| Overturf, GD | 1 |
| Schantz, PM | 1 |
| Michel-Harder, C | 1 |
| Gubler, C | 1 |
| Chermette, R | 1 |
| Bussiéras, J | 1 |
| Mialot, M | 1 |
| Raynal, PC | 1 |
| Rowedder, A | 1 |
| Schafroth, E | 1 |
| Schlup, P | 1 |
| Na-Bangchang, K | 1 |
| Vanijanonta, S | 3 |
| Karbwang, J | 1 |
| Corona, T | 2 |
| Lugo, R | 1 |
| Medina, R | 1 |
| Brouwer, RE | 1 |
| Thijssen, H | 1 |
| van der Meer, JW | 1 |
| Overbosch, D | 3 |
| Gonzales, AE | 1 |
| Gavidia, CM | 1 |
| Tsang, VC | 1 |
| Bernal, T | 1 |
| Falcon, N | 1 |
| Romero, M | 1 |
| Lopez-Urbina, MT | 1 |
| Thomson, AJ | 1 |
| Buitrago, M | 1 |
| Edwards, B | 1 |
| Rosner, F | 1 |
| Nagayama, M | 1 |
| Shinohara, Y | 1 |
| Nagakura, K | 1 |
| Izumi, Y | 1 |
| Takagi, S | 1 |
| Maiti, B | 1 |
| Gonsebatt, ME | 1 |
| Sachdeva, RS | 1 |
| Manchanda, SK | 1 |
| Abrol, S | 1 |
| Wadhwa, SC | 1 |
| Ramachandran, KA | 1 |
| Paparone, PW | 1 |
| Menghetti, RA | 1 |
| Oka, Y | 1 |
| Fukui, K | 1 |
| Shoda, D | 1 |
| Abe, T | 1 |
| Kumon, Y | 1 |
| Sakaki, S | 1 |
| Torii, M | 1 |
| Bang, OY | 1 |
| Heo, JH | 1 |
| Choi, SA | 1 |
| Kim, DI | 1 |
| Alla, P | 1 |
| Del Giudice, P | 1 |
| Bernard, E | 1 |
| Perrin, C | 1 |
| Marty, P | 2 |
| Le Fichoux, Y | 1 |
| Ortonne, JP | 1 |
| Michiels, JF | 1 |
| Dellamonica, P | 1 |
| Weisse, ME | 1 |
| Raszka, WV | 1 |
| Aggarwal, SP | 1 |
| Sabharwal, BD | 1 |
| Visudhiphan, P | 1 |
| Chiemchanya, S | 1 |
| Proaño, JV | 1 |
| García, L | 1 |
| García-Torres, E | 1 |
| Correa, D | 4 |
| Fong, GC | 1 |
| Cheung, RT | 1 |
| Sekhar, GC | 1 |
| Lemke, BN | 1 |
| Ostrosky, P | 2 |
| Mehta, SS | 1 |
| Hatfield, S | 1 |
| Jessen, L | 1 |
| Vogel, D | 1 |
| Jung, H | 5 |
| Guo, H | 1 |
| Zhao, ZF | 1 |
| Shi, DZ | 1 |
| Escobar, A | 1 |
| Takayanagui, OM | 3 |
| Chimelli, L | 1 |
| Cook, GC | 2 |
| Wiegand, F | 1 |
| Koeppen, S | 1 |
| Häussermann, P | 1 |
| Delcker, A | 1 |
| Kitchen, LW | 1 |
| Grossklaus, D | 1 |
| Koske, JK | 1 |
| Moses, PD | 1 |
| Kirubakaran, C | 1 |
| Chacko, DS | 1 |
| Bills, DC | 1 |
| Symon, L | 1 |
| Pejaver, RK | 1 |
| Bartolomei, F | 1 |
| Nicoli, F | 1 |
| Swiader, L | 1 |
| Gastaut, JL | 1 |
| Jain, MK | 2 |
| Gupta, S | 2 |
| Katiyar, JC | 2 |
| Singh, SP | 1 |
| Srivastava, VM | 1 |
| Zhu, S | 1 |
| Vazquez, V | 1 |
| Jardim, E | 1 |
| Jena, A | 1 |
| Sanchetee, PC | 1 |
| Tripathi, R | 1 |
| Jain, RK | 1 |
| Gupta, AK | 1 |
| Sapra, ML | 1 |
| Torres, A | 1 |
| Villalobos, AN | 1 |
| de Aluja, AS | 2 |
| Navarro, R | 1 |
| Shriqui, CL | 1 |
| Milette, PC | 1 |
| Cohen, L | 1 |
| Belec, L | 1 |
| Sanson, M | 1 |
| Pierrot-Deseilligny, C | 1 |
| Signoret, JL | 1 |
| Placenua, M | 1 |
| Maitra, SC | 1 |
| Klinker, H | 1 |
| Tintelnot, K | 1 |
| Joeres, R | 1 |
| Müller, J | 2 |
| Gross, U | 1 |
| Schmidt-Rotte, H | 1 |
| Landwehr, P | 1 |
| Richter, E | 1 |
| Choi, JH | 2 |
| Chung, SI | 1 |
| Whang, YS | 1 |
| Lee, JD | 1 |
| Lim, HO | 1 |
| Chang, SH | 1 |
| Jung, KM | 1 |
| Rhie, S | 1 |
| Vazquez, ML | 2 |
| Sanchez, M | 3 |
| Penagos, P | 4 |
| Lin, CY | 1 |
| Fan, PC | 1 |
| Garcia-Dominguez, C | 1 |
| Rabiela, MT | 1 |
| Mason, PR | 1 |
| Bozdech, V | 1 |
| Girgis, KM | 1 |
| Puri, V | 2 |
| Sharma, DK | 1 |
| Kumar, S | 1 |
| Choudhury, V | 1 |
| Gupta, RK | 1 |
| Khalil, A | 1 |
| Cruz, M | 2 |
| Cruz, I | 1 |
| Horton, J | 1 |
| Bunnag, D | 2 |
| Riganti, M | 1 |
| de Queiroz, AC | 1 |
| Andrade Filho, Ade S | 1 |
| Antoniuk, SA | 1 |
| Bruck, I | 1 |
| Wittig, E | 1 |
| Accorsi, A | 1 |
| Allcut, DA | 1 |
| Coulthard, A | 1 |
| Davis, LE | 1 |
| Kornfeld, M | 1 |
| Bouree, P | 1 |
| Jia, JY | 1 |
| Fernández-Rodríguez, R | 1 |
| Ozaita, G | 1 |
| Viso, A | 1 |
| García-Mata, R | 1 |
| Gómez, A | 1 |
| Fernández, O | 1 |
| Chong, MS | 1 |
| Hawkins, CP | 1 |
| Hawkes, CH | 1 |
| Kocen, RS | 1 |
| Hagelskjaer, LH | 1 |
| Hansen, NJ | 1 |
| Christensen, T | 1 |
| Fandiño, J | 2 |
| Botana, C | 2 |
| Fandiño, C | 1 |
| Rodriguez, D | 1 |
| Gomez-Bueno, J | 2 |
| Diaz Camacho, SP | 1 |
| Candil Ruiz, A | 1 |
| Suate Peraza, V | 1 |
| Zazueta Ramos, ML | 1 |
| Felix Medina, M | 1 |
| Lozano, R | 1 |
| Willms, K | 1 |
| Alarcón, F | 2 |
| Dueñas, G | 1 |
| Moncayo, J | 1 |
| Escalante, L | 1 |
| Chowdhury, V | 1 |
| Gulati, P | 1 |
| Mehndiratta, MM | 2 |
| Gupta, M | 2 |
| Barros, NG | 1 |
| Bacheschi, LA | 1 |
| Vianna, LG | 1 |
| Macedo, V | 1 |
| Mello, P | 1 |
| Souza, HA | 1 |
| Costa, JM | 2 |
| Jagota, SC | 1 |
| Bequet, D | 1 |
| Goasguen, J | 1 |
| Aubry, P | 1 |
| Ndayiragije, A | 1 |
| Kamanfu, G | 1 |
| Nikoyagize, E | 1 |
| Nzeyimana, H | 1 |
| Bigirimana, V | 1 |
| Marerwa, G | 1 |
| Bittencourt, PR | 3 |
| Gracia, CM | 3 |
| Gorz, AM | 3 |
| Mazer, S | 2 |
| Oliveira, TV | 3 |
| Gonzalez, D | 3 |
| Stephano, A | 1 |
| Hurtado, M | 2 |
| Medina, MT | 2 |
| Joubert, J | 4 |
| Van As, AD | 1 |
| Costa, AJ | 1 |
| Heap, BJ | 1 |
| Jenni, WK | 1 |
| Shkurovich, M | 2 |
| Cohen, S | 2 |
| Rodriguez-del-Rosal, E | 1 |
| Collado, M | 1 |
| Fernandez, B | 2 |
| Crimmins, D | 1 |
| Collignon, PJ | 1 |
| Dwyer, D | 1 |
| Danta, G | 1 |
| Tesfa-Yohannes, TM | 1 |
| Moodley, M | 2 |
| Gupta, R | 1 |
| Yadav, NV | 1 |
| Fleet, WF | 1 |
| Morgan, HJ | 1 |
| Lile, S | 1 |
| Keilbach, NM | 1 |
| Sarti-Gutierrez, E | 1 |
| Pham, HT | 1 |
| Rim, HJ | 1 |
| Joo, KH | 1 |
| Fernandez, E | 1 |
| Collado, MA | 1 |
| de Toffol, B | 1 |
| Lewin-Fouks, P | 1 |
| Markabi, S | 1 |
| Larmande, P | 1 |
| Autret, A | 1 |
| Moosa, A | 1 |
| Matschke, HJ | 1 |
| Flentje, B | 1 |
| Lippmann, P | 1 |
| Hackebeil, C | 1 |
| Abel, W | 1 |
| Guerreiro, MM | 1 |
| Facure, NO | 1 |
| Guerreiro, CA | 1 |
| Misra, SC | 2 |
| Mansharamani, GG | 2 |
| King, CH | 1 |
| Mahmoud, AA | 1 |
| Estañol, B | 1 |
| Juárez, H | 1 |
| Irigoyen, Mdel C | 1 |
| González-Barranco, D | 1 |
| Rawlings, D | 1 |
| Ferriero, DM | 1 |
| Messing, RO | 1 |
| Pansey, BK | 1 |
| Basra, KS | 1 |
| Pasricha, R | 1 |
| Rodríguez, M | 1 |
| Pastor, A | 1 |
| Viladrich, A | 1 |
| De Carvalho-Filho, P | 1 |
| Arruda, OM | 1 |
| De Melo-Souza, SE | 1 |
| Alvarez Sabin, J | 1 |
| Espinach, J | 1 |
| Boada, M | 1 |
| Codina Puiggros, A | 1 |
| Teitelbaum, GP | 1 |
| Otto, RJ | 1 |
| Lin, M | 1 |
| Watanabe, AT | 1 |
| Stull, MA | 1 |
| Manz, HJ | 1 |
| Bradley, WG | 1 |
| Davis, A | 1 |
| Dixon, H | 1 |
| Pawlowski, ZS | 1 |
| Proano, J | 1 |
| Parker, F | 1 |
| Hladky, JP | 1 |
| Breton, JO | 1 |
| Mignard, C | 1 |
| Laporte, JP | 1 |
| Bousquet, C | 1 |
| Minnick, A | 1 |
| Wu, ZD | 1 |
| Quintero-Rodriguez, E | 1 |
| Abad, JM | 1 |
| Fernańdez, J | 1 |
| Bollar, A | 1 |
| Gelabert, M | 1 |
| Mostaza, A | 1 |
| García-Allut, A | 1 |
| Madhu, S | 1 |
| Sehra, D | 1 |
| Aggarwal, SK | 1 |
| Verma, NP | 1 |
| Nii, Y | 1 |
| Nakagawa, H | 1 |
| Taki, T | 1 |
| Nakabayashi, T | 1 |
| Parikh, PM | 1 |
| Anjaria, PD | 1 |
| Chile, VS | 1 |
| Van Linthoudt, D | 1 |
| Robert, CF | 1 |
| Ott, H | 1 |
| Gari-Toussaint, M | 1 |
| Lanteri-Minet, M | 1 |
| Barres, P | 1 |
| Hoffman, P | 1 |
| Onzon, D | 1 |
| Richelme, C | 1 |
| Cervera, P | 1 |
| Mary, C | 1 |
| Coussement, A | 1 |
| Mitchell, WG | 1 |
| Crawford, TO | 1 |
| van Dellen, JR | 1 |
| McKeown, CP | 1 |
| Braconier, JH | 1 |
| Christensson, B | 1 |
| Pérez, Y | 1 |
| Banda, H | 1 |
| Wadia, N | 1 |
| Desai, S | 1 |
| Bhatt, M | 1 |
| Krivoy, A | 1 |
| Casale, E | 1 |
| Valdivia, RD | 1 |
| Silva, V | 1 |
| Gonzalez, A | 1 |
| Woo, E | 1 |
| Yu, YL | 1 |
| Huang, CY | 1 |
| Rosselli, A | 1 |
| Rosselli, M | 1 |
| Ardila, A | 1 |
| Penagos, B | 1 |
| Hautecoeur, P | 1 |
| Gallois, P | 1 |
| Brucher, JM | 1 |
| Ovelacq, E | 1 |
| Dereux, JF | 1 |
| Zhai, YC | 1 |
| Zhan, QM | 1 |
| Feng, YQ | 1 |
| Li, ZR | 1 |
| Kalra, V | 1 |
| Deorari, AK | 1 |
| Goulatia, RK | 1 |
| Pascoe, M | 1 |
| Saines, N | 1 |
| Lyall, I | 1 |
| Nolan, C | 1 |
| Buri, AC | 1 |
| Gyr, K | 1 |
| Reinhardt, H | 1 |
| Mateos-Gomez, H | 1 |
| Zenteno Alanis, G | 1 |
| Dworecki, J | 1 |
| Gordillo-Paniagua, G | 1 |
| Muñoz-Arizpe, R | 1 |
| Ponsa-Molina, R | 1 |
| Thie, A | 1 |
| Lachenmayer, L | 1 |
| Bialek, R | 1 |
| Kunze, K | 1 |
| Schwartz, A | 1 |
| Aulich, A | 1 |
| Hammer, B | 1 |
| Martínez Vázquez, C | 1 |
| Ocampo, A | 1 |
| Pena, A | 1 |
| Hernansanz, J | 1 |
| Mancuso, P | 1 |
| Guarnera, F | 1 |
| Augello, G | 1 |
| Chiaramonte, I | 1 |
| D'Aliberti, G | 1 |
| Tropea, R | 1 |
| van de Nes, JC | 1 |
| Groll, E | 2 |
| Diekmann, HW | 2 |
| Polderman, AM | 1 |
| Mattie, H | 1 |
| Leblanc, R | 1 |
| Knowles, KF | 1 |
| Melanson, D | 1 |
| MacLean, JD | 1 |
| Rouleau, G | 1 |
| Farmer, JP | 1 |
| Gerken, G | 1 |
| Roth, R | 1 |
| Manns, M | 1 |
| Poralla, T | 1 |
| Hütteroth, TH | 1 |
| Meyer zum Büschenfelde, KH | 1 |
| Levin, JA | 1 |
| Smith, JG | 1 |
| Johnson, RB | 1 |
| Catapano, MS | 1 |
| Marx, JA | 1 |
| Kapadia, C | 1 |
| Rosenthal, RE | 1 |
| Emsellem, HA | 1 |
| Kline, PP | 1 |
| von Ploetz, K | 1 |
| Musial, T | 1 |
| Neu, IS | 1 |
| Genís Batlle, D | 1 |
| Geli Fábregas, M | 1 |
| Grau Martín, A | 1 |
| Vila Calveras, F | 1 |
| Coulanges, P | 1 |
| Ramaholimihaso, F | 1 |
| Randrianonimandimby, J | 1 |
| Bussone, G | 2 |
| Frediani, F | 1 |
| Lamperti, E | 1 |
| Salmaggi, A | 1 |
| Campi, A | 1 |
| Sinatra, MG | 1 |
| Boiardi, A | 1 |
| Sedano, AM | 1 |
| Vargas-Tentori, N | 1 |
| Galindo-Virgen, S | 1 |
| Rodriguez, J | 1 |
| Brown, WJ | 1 |
| Voge, M | 1 |
| Lé, CT | 1 |
| Igra, J | 1 |
| Xu, ZB | 1 |
| Zhong, HL | 1 |
| Feng, ML | 1 |
| Cao, WJ | 1 |
| Hewlett, EL | 1 |
| Zeng, MG | 1 |
| Tao, XX | 1 |
| Joubert, MJ | 1 |
| Lombaard, CM | 1 |
| Rana, PV | 1 |
| Kestelyn, P | 1 |
| Taelman, H | 1 |
| Mateos Gómez, H | 1 |
| Minoli, L | 1 |
| Senaldi, G | 1 |
| Malfitano, M | 1 |
| Marone, P | 1 |
| de Rezende, GL | 1 |
| Singhal, BS | 1 |
| Sowani, AM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis[NCT00001912] | 6 participants (Actual) | Observational | 1999-08-10 | Completed | |||
| Phase I Study of Oxfendazole (Toward the Treatment of Neurocysticercosis)[NCT01584362] | Phase 1 | 0 participants (Actual) | Interventional | 2016-08-31 | Withdrawn (stopped due to study conducted under Clinical Trials Agreement as NIAID registration NCT02234570) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
38 reviews available for praziquantel and Coenuri Infection
| Article | Year |
|---|---|
Systematic review of the effectiveness of selected drugs for preventive chemotherapy for Taenia solium taeniasis.
Topics: Albendazole; Animals; Anticestodal Agents; Chemoprevention; Cysticercosis; Humans; Niclosamide; Praz | 2020 |
Current status of taeniasis and cysticercosis in Vietnam.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Cattle; Cattle Diseases; Cysticercosis; F | 2014 |
Orbital cysticercosis, case report and review.
Topics: Albendazole; Animals; Cysticercosis; Cysticercus; Drug Therapy, Combination; Eye Infections, Parasit | 2011 |
Taeniasis and cysticercosis due to Taenia solium in Japan.
Topics: Adult; Albendazole; Animals; Anthelmintics; Cysticercosis; Diatrizoate Meglumine; Female; Humans; In | 2012 |
Taeniasis/cysticercosis in Bali, Indonesia.
Topics: Animals; Anthelmintics; Cysticercosis; DNA, Helminth; DNA, Mitochondrial; Health Surveys; Humans; In | 2011 |
Human case management and treatment of cysticercosis.
Topics: Adrenal Cortex Hormones; Albendazole; Animals; Case Management; Counseling; Cysticercosis; Cysticerc | 2003 |
Measures for the prevention and control of Taenia solium taeniosis and cysticercosis.
Topics: Animals; Cysticercosis; Disease Management; Health Education; Humans; Mass Screening; Niclosamide; P | 2003 |
Current status of cysticercosis in Vietnam.
Topics: Adolescent; Adult; Age Factors; Aged; Albendazole; Animals; Cattle; Communicable Diseases, Emerging; | 2003 |
Cysticercosis update.
Topics: Anticonvulsants; Brain Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel; Steroids | 1984 |
Recent advances in the diagnosis and treatment of cerebral cysticercosis.
Topics: Brain Diseases; Cysticercosis; Humans; Hydrocephalus; Praziquantel; Prognosis; Serologic Tests; Taen | 1984 |
Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients.
Topics: Adolescent; Adult; Albendazole; Animals; Antibodies, Helminth; Brain Diseases; Cerebrospinal Fluid S | 1993 |
Taeniasis and cysticercosis.
Topics: Adrenal Cortex Hormones; Albendazole; Animals; Brain; Cysticercosis; Humans; Praziquantel; Taeniasis | 1993 |
Therapy for neurocysticercosis: a reappraisal.
Topics: Albendazole; Cysticercosis; Eye Infections, Parasitic; Humans; Nervous System Diseases; Praziquantel | 1993 |
Cerebral cysticercosis.
Topics: Adult; Animals; Brain Neoplasms; Combined Modality Therapy; Cysticercosis; Diagnostic Errors; Enceph | 1993 |
Distinctive serial magnetic resonance changes in a young woman with rapidly evolved neurocysticercosis, with positron emission tomography results.
Topics: Adult; Antiplatyhelmintic Agents; Brain; Brain Diseases; Cysticercosis; Deoxyglucose; Female; Fluori | 1996 |
Neurocysticercosis--an update.
Topics: Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Central Nervous System Diseases; Cysticercosi | 1995 |
Cerebral cysticercosis manifesting as hydrocephalus--case report.
Topics: Aged; Animals; Antiplatyhelmintic Agents; Brain Diseases; Combined Modality Therapy; Cysticercosis; | 1996 |
[Subcutaneous cysticercosis].
Topics: Adult; Antiparasitic Agents; Antiplatyhelmintic Agents; Brain Diseases; Cysticercosis; Epilepsy; Hum | 1996 |
Cestode infection in children.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Anticestodal Agents; Antiplatyhelmintic Agents; Ces | 1996 |
Treatment of brain cysticercosis.
Topics: Albendazole; Anthelmintics; Anti-Inflammatory Agents; Brain Diseases; Cysticercosis; Dexamethasone; | 1997 |
Genotoxic activity of praziquantel.
Topics: Animals; Antiplatyhelmintic Agents; Carcinogenicity Tests; Carcinogens; Clinical Trials as Topic; Cr | 1997 |
Albendazole versus praziquantel for neurocysticercosis.
Topics: Albendazole; Animals; Anthelmintics; Antiplatyhelmintic Agents; Cysticercosis; Cysticercus; Encephal | 1998 |
Pharmacokinetic optimisation of the treatment of neurocysticercosis.
Topics: Absorption; Albendazole; Animals; Anthelmintics; Biological Availability; Brain Diseases; Cysticerco | 1998 |
Cysticercosis and epilepsy: a critical review.
Topics: Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Brain; Brain Diseases; Clinical Trials as Top | 1998 |
Taeniasis and cysticercosis.
Topics: Antiplatyhelmintic Agents; Cysticercosis; Humans; Praziquantel; Taeniasis | 1998 |
[Neurocysticercosis. Current review of the literature based on a long-term study of 2 clinically distinct German cases].
Topics: Brain; Brain Diseases; Combined Modality Therapy; Cysticercosis; Follow-Up Studies; Humans; Hydrocep | 1999 |
Case studies in international medicine.
Topics: Adolescent; Albendazole; Anti-Infective Agents; Antinematodal Agents; Antiplatyhelmintic Agents; Ant | 1999 |
Cerebral neurocysticercosis--case report and review.
Topics: Brain Diseases; Child; Cysticercosis; Humans; Male; Praziquantel | 1992 |
Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.
Topics: Albendazole; Central Nervous System Diseases; Cimetidine; Cysticercosis; Diagnosis, Differential; Di | 1992 |
Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects.
Topics: Albendazole; Animals; Brain Diseases; Cysticercosis; Humans; Magnetic Resonance Imaging; Meninges; P | 1991 |
Clinical, radiological and cerebrospinal fluid presentation of neurocysticercosis: a prospective study.
Topics: Adolescent; Adult; Central Nervous System Diseases; Child; Child, Preschool; Cysticercosis; Female; | 1990 |
[A cerebrospinal fluid syndrome in neurocysticercosis].
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Antibody Formation; Central Nervous System Disease | 1987 |
Treatment of neurocysticercosis: is praziquantel the new hope?
Topics: Brain Diseases; Cysticercosis; Evaluation Studies as Topic; Humans; Praziquantel | 1989 |
Drugs five years later: praziquantel.
Topics: Animals; Brain Diseases; Costs and Cost Analysis; Cysticercosis; Echinococcosis; Humans; Praziquante | 1989 |
[Recent developments in the treatment of cysticercosis by traditional Chinese medicine and western medicine].
Topics: Acupuncture Therapy; Adolescent; Adult; Aged; Albendazole; Anthelmintics; Benzimidazoles; Child; Cys | 1985 |
Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment.
Topics: Acute Disease; Adolescent; Adult; Animals; Black People; Brain Diseases; Calcinosis; Carbamazepine; | 1988 |
[Treatment of cerebral cysticercosis with praziquantel].
Topics: Adult; Brain; Cysticercosis; Encephalitis; Humans; Male; Praziquantel | 1986 |
Cysticercosis. A modern day plague.
Topics: Adolescent; Animals; Anthelmintics; Brain; Child; Child, Preschool; Clinical Trials as Topic; Cystic | 1985 |
10 trials available for praziquantel and Coenuri Infection
| Article | Year |
|---|---|
Is the course of neurocysticercosis modified by treatment with antihelminthic agents?
Topics: Adult; Aged; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Drug Therapy, Combination; F | 1995 |
Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Brain; Child; Cysticercosis; Female; Humans | 1995 |
Plasma concentrations of praziquantel during the therapy of neurocysticerosis with praziquantel, in the presence of antiepileptics and dexamethasone.
Topics: Adult; Anticonvulsants; Antiplatyhelmintic Agents; Biological Availability; Brain Diseases; Cysticer | 1995 |
Effective, single-dose treatment or porcine cysticercosis with oxfendazole.
Topics: Animals; Anthelmintics; Benzimidazoles; Brain; Cysticercosis; Cysticercus; Drug Therapy, Combination | 1996 |
Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
Topics: Adult; Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Brain Diseases; Cerebral Ventricles; C | 1997 |
Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Cerebrospinal Fluid; Child; Child, Preschool; Cystic | 1992 |
Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis.
Topics: Adult; Albendazole; Brain; Brain Diseases; Cysticercosis; Electroencephalography; Female; Follow-Up | 1991 |
Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; F | 1990 |
[Neurocysticercosis. II. Evaluation of treatment with praziquantel].
Topics: Adolescent; Adult; Brain Diseases; Child; Child, Preschool; Clinical Trials as Topic; Cysticercosis; | 1990 |
Cysticercosis. A modern day plague.
Topics: Adolescent; Animals; Anthelmintics; Brain; Child; Child, Preschool; Clinical Trials as Topic; Cystic | 1985 |
245 other studies available for praziquantel and Coenuri Infection
| Article | Year |
|---|---|
Case Report: Disseminated Cysticercosis due to Intentional Ingestion of Parasitic Worm Eggs for Weight Loss.
Topics: Albendazole; Animals; Anthelmintics; Brain; Cysticercosis; Female; Humans; Liver; Muscles; Peritoneu | 2021 |
Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
Topics: Albendazole; Animals; Anthelmintics; Blood-Brain Barrier; Cysticercosis; Drug Combinations; Mebendaz | 2020 |
Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Albendazole; Animals; Ant | 2020 |
Acute pancytopenia due to praziquantel treatment for cerebral cysticercosis: A rare case report.
Topics: Aged; Cysticercosis; Humans; Male; Middle Aged; Neurocysticercosis; Pancytopenia; Praziquantel | 2020 |
The data are inadequate to assess safety and efficacy of mass chemotherapy for Taenia solium taeniasis.
Topics: Albendazole; Animals; Cysticercosis; Praziquantel; Taenia solium; Taeniasis | 2020 |
Subarachnoid racemose neurocysticercosis with cerebellar involvement: an old friend in an infrequent location?
Topics: Cysticercosis; Friends; Humans; Neurocysticercosis; Praziquantel | 2021 |
Case Report: Cysticercosis: Sonographic Diagnosis of a Treatable Cause of Epilepsy and Skin Nodules.
Topics: Adult; Albendazole; Animals; Brain; Cysticercosis; Epilepsy; Female; Humans; Muscle, Skeletal; Prazi | 2017 |
[Treatment and nursing of a cysticercosis patient with multiple foci].
Topics: Animals; Antiparasitic Agents; Brain Diseases; Cysticercosis; Diet; Humans; Male; Praziquantel; Red | 2018 |
Perceptions and acceptability of piloted Taenia solium control and elimination interventions in two endemic communities in eastern Zambia.
Topics: Adolescent; Adult; Animals; Anthelmintics; Antibodies, Helminth; Communicable Disease Control; Cysti | 2020 |
It isn't always caviar.
Topics: Albendazole; Animals; Anthelmintics; Cysticercosis; Debridement; Diagnosis, Differential; Fasciitis, | 2014 |
Acute visceral cysticercosis by Taenia hydatigena in lambs and treatment with praziquantel.
Topics: Acute Disease; Animals; Anthelmintics; Cysticercosis; Cysticercus; Female; Liver; Praziquantel; Shee | 2016 |
Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
Topics: Albendazole; Animals; Anthelmintics; Cysticercosis; Cysticercus; Disease Models, Animal; Drug Admini | 2015 |
Successful Antiparasitic Treatment for Cysticercosis is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model.
Topics: Albendazole; Animals; Anticestodal Agents; Antigens, Helminth; Benzimidazoles; Cysticercosis; Diseas | 2015 |
Elucidating the influence of praziquantel nanosuspensions on the in vivo metabolism of Taenia crassiceps cysticerci.
Topics: Animals; Cysticercosis; Cysticercus; Mice; Mice, Inbred BALB C; Nanoparticles; Praziquantel; Taenia | 2016 |
Education and imaging. Gastrointestinal: beef tapeworm (Taenia saginata).
Topics: Abdominal Pain; Animals; Anthelmintics; Capsule Endoscopy; Cattle; Cysticercosis; Cysticercus; Endos | 2008 |
Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci.
Topics: Albendazole; Animals; Anthelmintics; Citric Acid Cycle; Cysticercosis; Cysticercus; Energy Metabolis | 2012 |
Fatty acids oxidation and alternative energy sources detected in Taenia crassiceps cysticerci after host treatment with antihelminthic drugs.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Albendazole; Animals; Anthelmintics; Creatinine; Cysticercosis | 2012 |
What is your diagnosis? Two well-circumscribed, mineralized opacities in the left caudal quadrant of the abdomen.
Topics: Animals; Anthelmintics; Cysticercosis; Cysticercus; Diagnosis, Differential; Male; Praziquantel; Rab | 2002 |
[A case report of bronchial cysticercosis].
Topics: Adult; Anthelmintics; Biopsy; Bronchial Diseases; Bronchoscopy; Combined Modality Therapy; Cysticerc | 2000 |
[Cysticercosis as a rare cause of a tumor of the tongue].
Topics: Adult; Anthelmintics; Cerebral Cortex; Combined Modality Therapy; Cysticercosis; Diagnosis, Differen | 2003 |
Case report: intraocular cysticercosis.
Topics: Adult; Animals; Anthelmintics; Cysticercosis; Eye Infections, Parasitic; Female; Humans; Meat Produc | 2003 |
In vitro effects of albendazole sulfoxide and praziquantel against Taenia solium and Taenia crassiceps cysts.
Topics: Albendazole; Animals; Anthelmintics; Antiplatyhelmintic Agents; Cysticercosis; Humans; Male; Mice; M | 2004 |
[Cysticercosis contracted in metropolitan France].
Topics: Animals; Anthelmintics; Antibodies, Helminth; Cysticercosis; Cysticercus; Enzyme-Linked Immunosorben | 2006 |
[Imported coenurosis in sheep].
Topics: Animals; Anthelmintics; Benzimidazoles; Brain; Brain Diseases; Cestode Infections; Cysticercosis; Di | 2006 |
[Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller].
Topics: Adult; Albendazole; Anthelmintics; Brain Edema; Combined Modality Therapy; Confusion; Cysticercosis; | 2004 |
[Clinical evaluation of Biltricide (praziquantel) in cysticercosis cellulosae].
Topics: Adolescent; Adult; Cysticercosis; Female; Humans; Isoquinolines; Male; Middle Aged; Praziquantel | 1982 |
[Subclinical cerebral cysticercosis and Biltricide (praziquantel)].
Topics: Adult; Brain Diseases; Cysticercosis; Female; Humans; Isoquinolines; Male; Middle Aged; Praziquantel | 1984 |
[Cerebral cysticercosis. Diagnostic findings and new therapeutic possibilities].
Topics: Adult; Aged; Brain Diseases; Cysticercosis; Diagnosis, Differential; Drug Therapy, Combination; Epil | 1983 |
[A clinical study on the treatment of cerebral cysticercosis with praziquantel].
Topics: Adolescent; Adult; Brain Diseases; Child; Cysticercosis; Female; Humans; Intracranial Pressure; Isoq | 1984 |
[Praziquantel in the treatment of helminthiasis].
Topics: Animals; Cysticercosis; Echinococcosis; Helminthiasis; Humans; Isoquinolines; Praziquantel; Schistos | 1984 |
Cysticercosis: a new hope.
Topics: Adult; Brain Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel | 1984 |
[Tumor form of neurocysticercosis: surgical removal of a cysticercus measuring 70X77 mm and treatment with praziquantel].
Topics: Adult; Brain Diseases; Brain Neoplasms; Cysticercosis; Diagnosis, Differential; Female; Humans; Isoq | 1984 |
Praziquantel for cysticercosis of the brain parenchyma.
Topics: Brain Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel | 1984 |
Treatment of cysticercosis with praziquantel.
Topics: Cysticercosis; Humans; Isoquinolines; Praziquantel | 1984 |
Cysticercosis and praziquantel therapy.
Topics: Adult; Brain Diseases; Cysticercosis; Humans; Isoquinolines; Male; Praziquantel | 1984 |
[Pure spinal cysticercosis. Note on the cerebrospinal fluid].
Topics: Cysticercosis; Follow-Up Studies; Humans; Laminectomy; Male; Middle Aged; Praziquantel; Sciatica; Sp | 1984 |
Subcutaneous and cerebral cysticercosis treated with praziquantel.
Topics: Adult; Antibodies; Antiparasitic Agents; Brain Diseases; Cysticercosis; Cysticercus; Female; Hemaggl | 1984 |
Successful treatment of neurocysticercosis with low-dose praziquantel.
Topics: Brain Diseases; Cysticercosis; Female; Humans; Isoquinolines; Middle Aged; Praziquantel | 1984 |
[New developments in the clinical study of praziquantel].
Topics: Clonorchiasis; Cysticercosis; Humans; Intestinal Diseases, Parasitic; Isoquinolines; Paragonimiasis; | 1984 |
Cerebral cysticercosis. Treatment with praziquantil.
Topics: Brain Diseases; Cysticercosis; Female; Humans; Isoquinolines; Praziquantel | 1984 |
Absorption of cysticerci in cattle after treatment of taenia saginata cysticercosis with praziquantel.
Topics: Animals; Cattle; Cattle Diseases; Cysticercosis; Cysticercus; Isoquinolines; Male; Praziquantel; Tae | 1984 |
[Effect of praziquantel in the treatment of 111 cases of cerebral cysticercosis cellulosae].
Topics: Adult; Aged; Brain; Brain Diseases; Cysticercosis; Female; Humans; Isoquinolines; Male; Middle Aged; | 1984 |
Failure of medical treatment in two cases of of intraocular cysticercosis.
Topics: Cysticercosis; Drug Therapy, Combination; Endophthalmitis; Humans; Isoquinolines; Praziquantel; Pred | 1984 |
[Effect of biltricide on cysticercosis cellulosae with muscular pseudodystrophy--report of 3 cases].
Topics: Adult; Cysticercosis; Female; Humans; Isoquinolines; Male; Muscular Dystrophies; Praziquantel | 1983 |
Medical management of neurocysticercosis with Praziquantel.
Topics: Brain Diseases; Cysticercosis; Humans; Isoquinolines; Kinetics; Praziquantel | 1983 |
Therapy of parenchymal brain cysticercosis with praziquantel.
Topics: Adolescent; Adult; Brain; Brain Diseases; Cysticercosis; Drug Evaluation; Female; Follow-Up Studies; | 1984 |
Cerebral cysticercosis: treatment with praziquantel. Report of two cases.
Topics: Adult; Antibodies; Brain; Brain Diseases; Cysticercosis; Cysticercus; Dexamethasone; Drug Therapy, C | 1984 |
[Cerebral cysticercosis. A report on the treatment with praziquantel].
Topics: Antibodies; Brain Diseases; Cysticercosis; Cysticercus; Hemagglutination Tests; Humans; Isoquinoline | 1984 |
Praziquantel therapy for cysticercosis.
Topics: Central Nervous System Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel | 1983 |
Duration of immunity and absorption of cysticerci in calves after treatment of Taenia saginata cysticercosis with praziquantel.
Topics: Age Factors; Animals; Cattle; Cattle Diseases; Cysticercosis; Cysticercus; Enzyme-Linked Immunosorbe | 1983 |
Efficacy of praziquantel against ovine cysticercosis caused by Taenia hydatigena.
Topics: Age Factors; Animals; Cysticercosis; Dose-Response Relationship, Drug; Female; Isoquinolines; Praziq | 1983 |
Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel.
Topics: Adult; Brain Diseases; Cysticercosis; Dexamethasone; Female; Humans; Isoquinolines; Praziquantel; To | 1983 |
Praziquantel: a major advance in anthelminthic therapy.
Topics: Animals; Cestode Infections; Cysticercosis; Dogs; Echinococcosis; Helminthiasis; Humans; Isoquinolin | 1983 |
[Treatment of cysticercosis using praziquantel. Preliminary report of 10 cases].
Topics: Adult; Brain Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel; Tomography, X-Ray Compute | 1983 |
Administration of praziquantel in neurocysticercosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Cysticercosis; Dexamethasone; Drug Evaluation; Drug Ther | 1982 |
New results on the effect of praziquantel in experimental cysticercosis.
Topics: Animals; Cysticercosis; Hymenolepis; Isoquinolines; Mice; Microscopy, Electron, Scanning; Praziquant | 1982 |
Treatment of cysticercosis with praziquantel in Colombia.
Topics: Adolescent; Adult; Brain; Colombia; Cysticercosis; Female; Hemagglutination Tests; Humans; Isoquinol | 1982 |
Morphological changes after treatment of bovine cysticercosis with droncit and oxichloron.
Topics: Animals; Anticestodal Agents; Bithionol; Cattle; Cattle Diseases; Cysticercosis; Cysticercus; Isoqui | 1981 |
[Neurocysticercosis and praziquantel. II. Evaluation of results in 20 patients].
Topics: Adrenal Cortex Hormones; Brain Diseases; Cysticercosis; Drug Interactions; Humans; Isoquinolines; Pr | 1981 |
[A clinical study of treating schistosomiasis and cysticercosis with praziquantel (author's transl)].
Topics: Adolescent; Adult; Aged; Cysticercosis; Female; Humans; Isoquinolines; Male; Middle Aged; Praziquant | 1981 |
[Medical treatment of cerebral cysticercosis].
Topics: Adult; Brain Diseases; Child; Cysticercosis; Female; Humans; Isoquinolines; Male; Praziquantel; Tomo | 1981 |
[Treatment of calves infested with Cysticercus bovis].
Topics: Animals; Cattle; Cattle Diseases; Cysticercosis; Cysticercus; Drug Evaluation, Preclinical; Mebendaz | 1980 |
[A case of successfully treated cerebral cysticercosis].
Topics: Brain Diseases; Child; Cysticercosis; Humans; Isoquinolines; Male; Praziquantel; Tomography, X-Ray C | 1980 |
Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel.
Topics: Adolescent; Adult; Aged; Cell Division; Cells, Cultured; Cysticercosis; Female; Gene Frequency; Huma | 1994 |
Subarachnoid neurocysticercosis with occlusion of the major intracranial arteries: case report.
Topics: Brain Diseases; Carotid Stenosis; Cerebral Angiography; Cerebral Infarction; Combined Modality Thera | 1995 |
Bovine cysticercosis: demonstration in experimentally infected calves of serum IgG antibodies reactive with neutral glycolipids of Taenia saginata and T. crassiceps metacestodes.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Carbohydrates; Cattle; Chromatography, Thin Layer | 1995 |
Hepatic cysticercosis. Report of an unusual case.
Topics: Adenocarcinoma; Biopsy; Colonic Neoplasms; Cysticercosis; Humans; Liver; Liver Diseases, Parasitic; | 1995 |
Racemose neurocysticercosis after chronic meningitis: effect of medical treatment.
Topics: Adult; Albendazole; Chronic Disease; Cysticercosis; Follow-Up Studies; Humans; Magnetic Resonance Im | 1995 |
[Muscle ache and vision disorders in a South American immigrant to Switzerland].
Topics: Adult; Cysticercosis; Eye Diseases; Humans; Male; Muscular Diseases; Pain; Praziquantel; Vision Diso | 1994 |
Medical treatment of cysticercosis--effective.
Topics: Albendazole; Cysticercosis; Humans; Nervous System Diseases; Praziquantel | 1995 |
[Epilepsy, intracranial hypertension, confusional syndrome and cutaneous cysticercosis. Apropos of 1 case observed in a hospital in Benin].
Topics: Adrenal Cortex Hormones; Benin; Confusion; Cysticercosis; Epilepsy; Humans; Intracranial Pressure; M | 1994 |
Advances in treatment of neurocysticercosis.
Topics: Albendazole; Brain Diseases; Controlled Clinical Trials as Topic; Cysticercosis; Drug Administration | 1994 |
Meningeal irritation: possible manifestation of cerebral Echinococcus infestation.
Topics: Adult; Animals; Antibodies, Helminth; Brain Diseases; Cysticercosis; Diagnosis, Differential; Echino | 1994 |
[27-year-old patient with nodules in the breast, tongue, subcutis and brain].
Topics: Adult; Brain; Brain Diseases; Breast; Breast Diseases; Cysticercosis; Dexamethasone; Drug Therapy, C | 1994 |
[Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel].
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Drug Therapy, Combi | 1994 |
Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel.
Topics: Adolescent; Adult; Antibodies, Helminth; Biopterins; Brain Diseases; Child; Cysticercosis; Enzyme-Li | 1995 |
The neurocysticercosis project in Atteridgeville-Mamelodi townships.
Topics: Adolescent; Adult; Brain Diseases; Child; Cysticercosis; Female; Humans; Incidence; Male; Middle Age | 1994 |
[Tapeworms in the brain--a current problem in Norway?].
Topics: Adult; Brain; Cysticercosis; Emigration and Immigration; Female; Humans; Magnetic Resonance Imaging; | 1994 |
[Cerebral cysticercosis treated with praziquantel--a case report].
Topics: Adult; Brain Diseases; Cysticercosis; Drug Administration Schedule; Humans; Male; Praziquantel | 1994 |
Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel.
Topics: Brain Diseases; Child; Cysticercosis; Female; Headache; Humans; Intestinal Diseases, Parasitic; Praz | 1993 |
Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants.
Topics: Adult; Anticonvulsants; Brain Diseases; Cimetidine; Cysticercosis; Drug Therapy, Combination; Humans | 1994 |
Prevalence, possible aetiologies, control and cost of parasitic lesions in three flocks of housed lambs.
Topics: Animal Husbandry; Animals; Cysticercosis; Dog Diseases; Dogs; Liver Diseases, Parasitic; Praziquante | 1994 |
Praziquantel therapy in neurocysticercosis.
Topics: Adolescent; Adult; Brain; Cysticercosis; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mi | 1993 |
Profuse neurocysticercosis with minimal signs and a favorable outcome.
Topics: Brain; Brain Diseases; Child, Preschool; Cysticercosis; Dexamethasone; Drug Therapy, Combination; Fe | 1993 |
Neurocysticercosis.
Topics: Adolescent; Adult; Albendazole; Antibodies, Helminth; Child; Child, Preschool; Cysticercosis; Enzyme | 1993 |
Neurocysticercosis in Houston, Texas. A report of 112 cases.
Topics: Adolescent; Adult; Animals; Brain Diseases; Child; Cysticercosis; Female; Humans; Male; Middle Aged; | 1994 |
Consensus: diagnosis and management of neurocysticercosis in children.
Topics: Adult; Albendazole; Brain; Central Nervous System Diseases; Child; Cysticercosis; Dexamethasone; Fec | 1993 |
Case 8-1993: cysticercosis.
Topics: Albendazole; Brain Diseases; Cysticercosis; Humans; Praziquantel; Subarachnoid Space | 1993 |
[A case from practice (272)--cerebral cysticercosis (neurocysticercosis)--infection with larvae of Taenia solium, swine tapeworm].
Topics: Adult; Animals; Brain Diseases; Cysticercosis; Female; Humans; Praziquantel; Pregnancy; Pregnancy Co | 1993 |
Subcutaneous Taenia crassiceps cysticercosis in a dog.
Topics: Animals; Antiparasitic Agents; Chemotherapy, Adjuvant; Cysticercosis; Cysticercus; Diagnosis, Differ | 1993 |
[Grand-mal epilepsy as initial manifestation of a parenchymal neuro_cysticercosis].
Topics: Adult; Animals; Antibodies, Helminth; Brain Diseases; Cysticercosis; Cysticercus; Enzyme-Linked Immu | 1993 |
Single-day praziquantel therapy for neurocysticercosis.
Topics: Adult; Antiplatyhelmintic Agents; Brain Diseases; Cysticercosis; Drug Administration Schedule; Femal | 1996 |
[2 patients with neurocysticercosis].
Topics: Adult; Anthelmintics; Brain Diseases; Brain Neoplasms; Cysticercosis; Diagnosis, Differential; Epile | 1995 |
Therapy with parasiticidal drugs in cysticercal encephalitis--is it indicated?
Topics: Albendazole; Animals; Anthelmintics; Antiplatyhelmintic Agents; Child, Preschool; Cysticercosis; Enc | 1996 |
Neurocysticercosis: Report of fifteen cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiplatyhelmintic Agents; Brain Diseases; Child; Cystic | 1995 |
Environmental toxicants in developing countries.
Topics: Animal Population Groups; Animals; Antiparasitic Agents; Brain Diseases; Carcinogens; Chromosome Abe | 1996 |
Freely mobile cysticercus in the anterior chamber.
Topics: Adult; Animals; Anterior Chamber; Anti-Inflammatory Agents; Anticonvulsants; Antiplatyhelmintic Agen | 1995 |
Case report: neurocysticercosis in pregnancy.
Topics: Adolescent; Anticonvulsants; Antiplatyhelmintic Agents; Brain Diseases; Cysticercosis; Epilepsy, Ton | 1996 |
Large cerebral infarction during praziquantel therapy in neurocysticercosis.
Topics: Antiplatyhelmintic Agents; Basal Ganglia; Brain Diseases; Carotid Artery, Internal; Cerebral Angiogr | 1997 |
[Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis].
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Humans; | 1996 |
Praziquantel therapy in neurocysticercosis.
Topics: Adult; Antiplatyhelmintic Agents; Biopsy; Brain Diseases; Cysticercosis; Humans; Male; Middle Aged; | 1995 |
Clues to prevent cerebrovascular hazards of cysticidal drug therapy.
Topics: Aged; Antiplatyhelmintic Agents; Cerebrovascular Disorders; Cysticercosis; Humans; Praziquantel | 1997 |
Acute cysticercal meningitis in children: response to praziquantel.
Topics: Acute Disease; Antiplatyhelmintic Agents; Child, Preschool; Cysticercosis; Female; Hemagglutination | 1997 |
Caution with praziquantel in neurocysticercosis.
Topics: Adult; Antiplatyhelmintic Agents; Central Nervous System Diseases; Cerebral Infarction; Cysticercosi | 1997 |
Orbital cysticercosis.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Conjunctiva; Conjun | 1997 |
A study on the culture medium antigens of Cystcercus cellulosae for detecting antibodies of cysticercosis by means of ABC-ELISA.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Culture Media; Cysticercosis; Enzyme-Linked Immun | 1997 |
Disseminated muscular cysticercosis with myositis induced by praziquantel therapy.
Topics: Adult; Anticestodal Agents; Cysticercosis; Female; Humans; Muscular Diseases; Myositis; Praziquantel | 1998 |
Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Albendazole; Animals; Anthelmintics; Brain Diseases; Car | 1999 |
[Effectiveness of praziquantel in experimental T. saginata cysticercosis in cattle].
Topics: Animals; Cattle; Cattle Diseases; Cysticercosis; Dose-Response Relationship, Drug; Drug Evaluation; | 1979 |
The efficacy of praziquantel against Taenia saginata cysticercosis in naturally infected calves.
Topics: Animals; Cattle; Cattle Diseases; Cysticercosis; Injections, Subcutaneous; Isoquinolines; Kenya; Pra | 1979 |
Disappearing CT lesions in focal seizures.
Topics: Brain Diseases; Child; Cysticercosis; Epilepsies, Partial; Female; Humans; Phenytoin; Praziquantel; | 1992 |
Cysticercosis producing various neurological presentations in a patient: case report.
Topics: Adult; Brain Diseases; Combined Modality Therapy; Cysticercosis; Dexamethasone; Female; Follow-Up St | 1992 |
[Value of experimental use of praziquantel in cases of isolated cerebral cysticercosis and follow-up of the evolution by MRI].
Topics: Adolescent; Brain Diseases; Cysticercosis; Female; Follow-Up Studies; Humans; Magnetic Resonance Ima | 1992 |
Alterations in metabolic activity of Cysticercus fasciolaris on some anthelmintic treatments.
Topics: Adenosine Triphosphate; Alanine; Animals; Anthelmintics; Benzimidazoles; Carbamates; Cysticercosis; | 1992 |
[A follow-up study of 420 cases of cerebral cysticercosis].
Topics: Adolescent; Adult; Aged; Brain Diseases; Child; Child, Preschool; Cysticercosis; Dexamethasone; Fema | 1992 |
The course of seizures after treatment for cerebral cysticercosis.
Topics: Adult; Albendazole; Brain; Brain Diseases; Cysticercosis; Epilepsy; Female; Follow-Up Studies; Human | 1992 |
MR observations on the effects of praziquantel in neurocysticercosis.
Topics: Adult; Brain; Brain Diseases; Cysticercosis; Female; Humans; Magnetic Resonance Imaging; Male; Prazi | 1992 |
Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 3. Effect of 1-day treatment.
Topics: Animals; Antibodies, Helminth; Brain; Brain Diseases; Cysticercosis; Cysticercus; Enzyme-Linked Immu | 1992 |
You drive me crazy: a case report of acute psychosis and neurocysticercosis.
Topics: Acute Disease; Adult; Brain Diseases; Cysticercosis; Dexamethasone; Electroencephalography; Female; | 1992 |
[Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Resistance; Drug Therapy, Combination; Follo | 1992 |
Definition of contemporary surgical management in cisternal and parenchymatous cysticercosis cerebri.
Topics: Albendazole; Cysticercosis; Follow-Up Studies; Humans; Neurologic Examination; Praziquantel; Tomogra | 1992 |
Substituted methyl benzimidazole carbamate: efficacy against experimental cysticercosis.
Topics: Animals; Anticestodal Agents; Benzimidazoles; Carbamates; Coleoptera; Cysticercosis; Cysticercus; Dr | 1992 |
[Taenia crassiceps infection in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Back; Cysticercosis; Cysticercus; Diagnosis, Dif | 1992 |
A case of pulmonary cysticercosis.
Topics: Aged; Cysticercosis; Humans; Lung Diseases, Parasitic; Male; Praziquantel | 1991 |
Clinical pharmacokinetics of praziquantel.
Topics: Adult; Brain Diseases; Chromatography, High Pressure Liquid; Cysticercosis; Female; Humans; Male; Mi | 1991 |
Evaluation of the efficacy of praziquantel against cysticercosis of a Taenia saginata-like tapeworm (Taiwan strain) in pigs.
Topics: Animals; Cysticercosis; Dose-Response Relationship, Drug; Praziquantel; Swine; Swine, Miniature | 1991 |
Praziquantel treatment of muscle Taenia solium cysticercosis. 4. Reversible in vitro effect.
Topics: Analysis of Variance; Animals; Cysticercosis; Cysticercus; Dose-Response Relationship, Drug; Helmint | 1991 |
Ocular cysticercosis: a case report and literature review.
Topics: Adolescent; Combined Modality Therapy; Cysticercosis; Eye Infections, Parasitic; Female; Humans; Pra | 1991 |
Neurocysticercosis in children.
Topics: Adolescent; Albendazole; Brain Diseases; Child; Child, Preschool; Cysticercosis; Drug Therapy, Combi | 1991 |
The treatment of neurocysticercosis with praziquantel.
Topics: Adult; Brain; Brain Diseases; Cysticercosis; Female; Follow-Up Studies; Humans; Intracranial Pressur | 1991 |
[Neurocysticercosis: neuropathologic study of a fatal case treated with praziquantel].
Topics: Adolescent; Brain Diseases; Cysticercosis; Humans; Male; Praziquantel | 1991 |
[Neurocysticercosis in childhood. II. Computed tomography of 24 patients according to symptomatic and praziquantel treatment].
Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Cysticercosis; Humans; Infant; | 1991 |
Neurocysticercosis: regression of a fourth ventricular cyst with praziquantel.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Brain Diseases; Cerebral Ventricles; Cysticerc | 1991 |
Successful treatment of Taenia saginata and Hymenolepis nana by single oral dose of praziquantel.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Cysticercosis; Humans; Hymenolepiasis; Hy | 1991 |
[Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel].
Topics: Adult; Brain Diseases; Chromatography, High Pressure Liquid; Cysticercosis; Female; Humans; Male; Mi | 1991 |
[Active and inactive forms of cerebral cysticercosis. Study of 10 cases].
Topics: Adolescent; Aged; Brain Diseases; Child; Cysticercosis; Female; Humans; Male; Middle Aged; Praziquan | 1991 |
A resistant case of neurocystercercosis.
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Resistance; Drug Therapy, Combination; Femal | 1991 |
[Cerebral cysticercosis].
Topics: Adult; Brain Diseases; Cysticercosis; Female; Humans; Magnetic Resonance Imaging; Malaysia; Praziqua | 1991 |
Clinical and radiographic response of fourth ventricle cysticercosis to praziquantel therapy.
Topics: Calcinosis; Cerebral Ventricles; Cerebral Ventriculography; Cerebrospinal Fluid Shunts; Cysticercosi | 1991 |
Epidemiologic study and control of Taenia solium infections with praziquantel in a rural village of Mexico.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Child; Child, Preschool; Cysticercosis; Feces; Hou | 1991 |
Neurocysticercosis.
Topics: Anticonvulsants; Brain Diseases; Cysticercosis; Humans; Praziquantel; Tomography, X-Ray Computed | 1991 |
Myoclonus: a manifestation of neurocysticercosis.
Topics: Brain Diseases; Child; Cysticercosis; Female; Humans; Myoclonus; Praziquantel; Valproic Acid | 1991 |
Neurocysticercosis.
Topics: Albendazole; Brain Diseases; Cysticercosis; Humans; Praziquantel | 1990 |
Computed tomography in neurocysticercosis: a 10-year long evolution analysis of 100 patients with an appraisal of a new classification.
Topics: Brain Diseases; Cysticercosis; Humans; Praziquantel; Prognosis; Retrospective Studies; Tomography, X | 1990 |
[Treatment of neurocysticercosis with praziquantel].
Topics: Adolescent; Adult; Central Nervous System Diseases; Cysticercosis; Dexamethasone; Drug Therapy, Comb | 1990 |
Neurocysticercosis.
Topics: Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Humans; Praziquantel | 1990 |
[Medical treatment of cysticercosis and monitoring of disease course using magnetic resonance imaging].
Topics: Adult; Brain Diseases; Cysticercosis; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; | 1990 |
[2 cases of cysticercosis in Burundi].
Topics: Adult; Burundi; Cysticercosis; Humans; Male; Praziquantel | 1990 |
High-dose praziquantel for neurocysticercosis: efficacy and tolerability.
Topics: Adolescent; Adult; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Cystice | 1990 |
Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Brain Diseases; Chromosomes; Cysticercosis; Cysti | 1990 |
Dexamethasone increases plasma levels of albendazole.
Topics: Adult; Albendazole; Cysticercosis; Dexamethasone; Drug Therapy, Combination; Female; Humans; Inflamm | 1990 |
High-dose praziquantel for neurocysticercosis: serum and CSF concentrations.
Topics: Administration, Oral; Cysticercosis; Humans; Praziquantel | 1990 |
Rapid and complete resolution of giant cysticercal cysts after administration of praziquantel. A report of 4 cases.
Topics: Adult; Brain Diseases; Cerebral Ventriculography; Cysticercosis; Female; Humans; Male; Middle Aged; | 1990 |
Cerebral cysticercosis as a common cause of epilepsy in Gurkhas in Hong Kong.
Topics: Adult; Brain Diseases; Cysticercosis; Enzyme-Linked Immunosorbent Assay; Epilepsy; Hong Kong; Humans | 1990 |
Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.
Topics: Adolescent; Adult; Age Factors; Aged; Albendazole; Brain Diseases; Child; Cysticercosis; Female; Hum | 1990 |
Treatment of neurocysticercosis.
Topics: Adult; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; | 1990 |
Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 1. Radiological, physiological and histopathological studies.
Topics: Animals; Biopsy; Brain; Cysticercosis; Cysticercus; Disease Models, Animal; Electrophysiology; Muscl | 1990 |
Neurocysticercosis: an under-recognized cause of neurological problems.
Topics: Adolescent; Adult; Aged; Australia; Cysticercosis; Diagnosis, Differential; Emigration and Immigrati | 1990 |
Cysticercal meningitis--a pernicious form of neurocysticercosis which responds poorly to praziquantel.
Topics: Adult; Chronic Disease; Cysticercosis; Female; Humans; Hydrocephalus; Male; Meningitis; Middle Aged; | 1990 |
Observations on self-induced Taenia saginata infection.
Topics: Animals; Cysticercosis; Feces; Humans; Parasite Egg Count; Praziquantel; Taenia | 1990 |
Treatment of neurocysticercosis with praziquantel.
Topics: Brain Diseases; Cysticercosis; Humans; Praziquantel | 1990 |
Failure of praziquantel and albendazole in neurocysticercosis.
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Follow-Up Studies; Hum | 1990 |
Cystic brain lesions in a Haitian man.
Topics: Adult; Anticestodal Agents; Brain Diseases; Cysticercosis; Diagnosis, Differential; Haiti; Humans; M | 1990 |
A programme to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village.
Topics: Adult; Animals; Child; Cysticercosis; Humans; Mexico; Patient Education as Topic; Praziquantel; Taen | 1989 |
Preliminary report of praziquantel treatment of cysticercosis patients in Vietnam.
Topics: Adult; Aged; Cysticercosis; Headache; Humans; Male; Middle Aged; Nervous System Diseases; Praziquant | 1989 |
Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis.
Topics: Adult; Antiparasitic Agents; Brain Diseases; Cysticercosis; Drug Tolerance; Female; Humans; Male; Mi | 1989 |
Swine cysticercosis treated with praziquantel, a short report.
Topics: Animals; Cysticercosis; Praziquantel; Swine; Swine Diseases | 1989 |
[Spontaneously resolving meningeal cysticercosis reveals chronic lymphocytic meningitis].
Topics: Chronic Disease; Cysticercosis; Humans; Male; Meningitis; Middle Aged; Praziquantel | 1989 |
Praziquantel for neurocysticercosis.
Topics: Adolescent; Adult; Brain Diseases; Child; Cysticercosis; Humans; Praziquantel | 1989 |
[Acute meningitis with cerebrospinal fluid eosinophilia: neurocysticercosis].
Topics: Acute Disease; Adolescent; Cerebrospinal Fluid; Cysticercosis; Eosinophilia; Humans; Leukocyte Count | 1989 |
[Cranial computed tomography aspects in neurocysticercosis in childhood].
Topics: Brain Diseases; Child; Cysticercosis; Diagnosis, Differential; Female; Humans; Male; Praziquantel; T | 1989 |
Praziquantel in neurocysticercosis.
Topics: Cysticercosis; Humans; Nervous System Diseases; Praziquantel | 1989 |
Reply from authors. Praziquantel in neurocysticercosis.
Topics: Brain Diseases; Cysticercosis; Dexamethasone; Drug Combinations; Humans; Praziquantel | 1989 |
[Neurocysticercosis and praziquantel: long-term development in 100 patients].
Topics: Adolescent; Adult; Aged; Brain Diseases; Child; Child, Preschool; Cysticercosis; Epilepsy; Female; F | 1989 |
Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel.
Topics: Adult; Animals; Antibody Formation; Antigen-Antibody Complex; Brain Diseases; Complement C3; Complem | 1989 |
Early CT reevaluation after empiric praziquantel therapy in neurocysticercosis.
Topics: Brain; Brain Diseases; Child; Cysticercosis; Female; Humans; Praziquantel; Tomography, X-Ray Compute | 1989 |
Medically treated neurocysticercosis in a blind child. A case report.
Topics: Blindness; Brain Diseases; Child, Preschool; Cysticercosis; Female; Headache; Humans; Praziquantel; | 1989 |
[Cerebral cysticercosis. 10 cases].
Topics: Adult; Aged; Brain Diseases; Cerebrospinal Fluid Shunts; Cysticercosis; Female; Humans; Magnetic Res | 1989 |
[Periodic lateralized epileptiform discharges in neurocysticercosis].
Topics: Central Nervous System Diseases; Child; Cysticercosis; Electroencephalography; Epilepsy, Temporal Lo | 1989 |
[Remission of a case of intraparenchymal neurocysticercosis following treatment with praziquantel].
Topics: Brain Diseases; Cysticercosis; Humans; Male; Middle Aged; Praziquantel | 1989 |
MR imaging of neurocysticercosis.
Topics: Adolescent; Adult; Aged; Brain; Brain Diseases; Child; Cysticercosis; Female; Humans; Magnetic Reson | 1989 |
Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cysticercosis; Disease Outbreaks; Ecuador; Female; | 1989 |
[Racemous cysticercosis of the cauda equina and cystic arachnoiditis. Apropos of 2 cases].
Topics: Adult; Arachnoiditis; Cauda Equina; Cysticercosis; Cysts; Female; Humans; Laminectomy; Male; Middle | 1988 |
Cysticercosis: etiology and nursing care.
Topics: Central Nervous System Diseases; Cysticercosis; Emigration and Immigration; Humans; Nursing Assessme | 1986 |
Praziquantel vs. albendazol for cysticercosis.
Topics: Albendazole; Anthelmintics; Benzimidazoles; Brain Diseases; Cysticercosis; Humans; Mexico; Praziquan | 1988 |
Brain cysticercosis treated with praziquantel. Report of six cases.
Topics: Adult; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged; Mycoses; Praziquantel; Tomo | 1988 |
Praziquantel in neurocysticercosis.
Topics: Brain Diseases; Cysticercosis; Female; Humans; Middle Aged; Praziquantel; Tomography, X-Ray Computed | 1988 |
[Successful treatment of cerebral cysticercosis with praziquantel].
Topics: Brain Diseases; Cysticercosis; Humans; Male; Middle Aged; Praziquantel; Tomography, X-Ray Computed | 1988 |
Problems in neurocysticercosis after praziquantel therapy.
Topics: Brain Diseases; Cysticercosis; Female; Humans; Middle Aged; Praziquantel; Prognosis | 1988 |
[Cutaneous and cerebral cysticercosis. Apropos of a case report in rheumatology].
Topics: Adult; Brain Diseases; Cysticercosis; Diagnosis, Differential; Female; Humans; Praziquantel; Skin Di | 1988 |
[Cerebral cysticercosis: imaging, serology, treatment and evolution. Apropos of 2 cases].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Brain Diseases; Cysticercosis; Humans; Magnetic Resonanc | 1988 |
Praziquantel in neurocysticercosis.
Topics: Cysticercosis; Humans; Male; Nervous System Diseases; Praziquantel | 1988 |
Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis.
Topics: Adolescent; Adult; Brain Diseases; Child; Child, Preschool; Cysticercosis; Dexamethasone; Drug Thera | 1988 |
Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial.
Topics: Adult; Albendazole; Benzimidazoles; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged | 1988 |
Cerebral cysticercosis successfully treated with praziquantel.
Topics: Adult; Brain Diseases; Cysticercosis; Female; Humans; Praziquantel; Tomography, X-Ray Computed | 1988 |
Praziquantel and dexamethasone.
Topics: Adult; Aged; Central Nervous System Diseases; Cysticercosis; Dexamethasone; Female; Humans; Male; Mi | 1988 |
Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel.
Topics: Adolescent; Adult; Brain; Carbamazepine; Child; Cysticercosis; Dexamethasone; Drug Therapy, Combinat | 1988 |
Parasitosis and mycosis of the central nervous system: 20 years of experience.
Topics: Central Nervous System Diseases; Child; Child, Preschool; Cysticercosis; Female; Humans; Infant; Ket | 1988 |
Cerebral infarct precipitated by praziquantel in neurocysticercosis--a cautionary note.
Topics: Aphasia; Brain Diseases; Cerebral Infarction; Cysticercosis; Hemiplegia; Hong Kong; Humans; Male; Mi | 1988 |
Severe dementia associated with neurocysticercosis.
Topics: Adolescent; Aphasia; Central Nervous System Diseases; Cysticercosis; Dementia; Dexamethasone; Female | 1988 |
[Association of cerebral cysticercosis and multifocal glioma. Discussion of interactions].
Topics: Brain Diseases; Brain Neoplasms; Cysticercosis; Female; Glioma; Humans; Middle Aged; Praziquantel | 1987 |
[An opinion on the treatment of cerebral cysticercosis with pyquiton].
Topics: Animals; Brain; Brain Diseases; Cysticercosis; Cysticercus; Humans; Male; Middle Aged; Praziquantel | 1987 |
[Further study on the effects of pyquiton in treating cerebral cysticercosis and criteria of its evaluation].
Topics: Adolescent; Adult; Brain Diseases; Child; Cysticercosis; Female; Humans; Hydrocephalus; Male; Middle | 1987 |
[Intracranial hypertensive type of cerebral cysticerosis (a report of 33 cases)].
Topics: Adolescent; Adult; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged; Praziquantel; P | 1987 |
[Therapeutic effect of pyquiton in the treatment of 52 cases of cerebral cysticerosis].
Topics: Adolescent; Adult; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged; Praziquantel | 1987 |
Praziquantel therapy in childhood neurocysticercosis.
Topics: Brain Diseases; Child; Child, Preschool; Cysticercosis; Female; Follow-Up Studies; Humans; Male; Pra | 1987 |
Cerebral cysticercosis: a case report with particular reference to recent advances in diagnosis and treatment.
Topics: Australia; Cysticercosis; Encephalitis; Humans; Male; Middle Aged; Praziquantel; Vietnam | 1987 |
[Neurocysticercosis].
Topics: Adult; Brain Diseases; Cerebral Ventriculography; Cysticercosis; Humans; Male; Praziquantel | 1986 |
Selective indications for the use of praziquantel in the treatment of brain cysticercosis.
Topics: Brain Diseases; Cerebral Ventriculography; Cysticercosis; Humans; Praziquantel; Tomography, X-Ray Co | 1987 |
Unusual complication in a patient with renal transplantation: cerebral cysticercosis.
Topics: Adolescent; Brain Diseases; Cysticercosis; Enzyme-Linked Immunosorbent Assay; Humans; Kidney Transpl | 1987 |
Cerebral cysticercosis in a European patient: problems of disease activity and therapeutic implications.
Topics: Adult; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Ph | 1987 |
[CT follow-up of neurocysticercosis treated with praziquantel].
Topics: Adult; Brain Diseases; Cysticercosis; Follow-Up Studies; Humans; Male; Middle Aged; Praziquantel; To | 1987 |
Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.
Topics: Adult; Brain Diseases; Cysticercosis; Dexamethasone; Drug Interactions; Female; Humans; Male; Middle | 1987 |
[Treatment of cysticercosis with praziquantel].
Topics: Brain Diseases; Cysticercosis; Humans; Praziquantel | 1987 |
Computed axial tomography versus NMR for the diagnosis of neurocysticercosis.
Topics: Brain Diseases; Cerebral Ventricles; Cysticercosis; Female; Humans; Magnetic Resonance Imaging; Midd | 1987 |
Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis.
Topics: Adult; Chromatography, Gas; Cysticercosis; Half-Life; Humans; Male; Praziquantel | 1987 |
Neurocysticercosis: surgical and medical management with praziquantel.
Topics: Adult; Brain Diseases; Cerebrospinal Fluid Shunts; Craniotomy; Cysticercosis; Female; Humans; Hydroc | 1986 |
[Neurocysticercosis. Diagnostic and therapeutic advances].
Topics: Adult; Brain Diseases; Combined Modality Therapy; Cysticercosis; Humans; Male; Praziquantel; Tomogra | 1986 |
Praziquantel in the treatment of cysticercosis.
Topics: Central Nervous System Diseases; Cysticercosis; Humans; Praziquantel | 1986 |
Potential hazard of mass praziquantel use.
Topics: Cysticercosis; Humans; Praziquantel; Schistosomiasis | 1986 |
Central nervous system cysticercosis simulating an acute cerebellar hemorrhage.
Topics: Acute Disease; Cerebellar Diseases; Cerebral Hemorrhage; Cysticercosis; Dexamethasone; Diagnosis, Di | 1986 |
Cerebral cysticercosis: treatment with praziquantel.
Topics: Brain; Brain Diseases; California; Cysticercosis; Drug Therapy, Combination; Female; Hispanic or Lat | 1986 |
Truncal seizures: an unusual presentation of cerebral cysticercosis.
Topics: Adult; Carbamazepine; Cysticercosis; Female; Humans; Movement Disorders; Praziquantel; Prednisone; S | 1986 |
[Cerebral manifestation of cysticercosis].
Topics: Brain Diseases; Cysticercosis; Electroencephalography; Evoked Potentials, Auditory; Humans; Magnetic | 1986 |
[Treatment of 2 cases of cysticercosis with praziquantel].
Topics: Adult; Cysticercosis; Humans; Male; Middle Aged; Praziquantel | 1986 |
[Cysticercosis in Madagascar (apropos of unusual bronchial localization)].
Topics: Adolescent; Adult; Aged; Bronchial Diseases; Child; Child, Preschool; Cysticercosis; Cysticercus; Fe | 1986 |
Neurocysticercosis: clinical and therapeutic considerations. Review of Italian literature.
Topics: Aged; Arachnoiditis; Cerebrospinal Fluid; Cysticercosis; Dexamethasone; Drug Therapy, Combination; E | 1986 |
Long-term results of praziquantel therapy in neurocysticercosis.
Topics: Adolescent; Adult; Aged; Brain Diseases; Child; Child, Preschool; Cysticercosis; Female; Follow-Up S | 1987 |
Case 11-1986: cysticercosis.
Topics: Cysticercosis; Dexamethasone; Female; Humans; Praziquantel | 1987 |
Albendazole therapy for neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Benzimidazoles; Brain Diseases; Cysticercosis; Female; Follow-Up | 1987 |
[ELISA (IgG and IgM) of the CSF and serum in neurocysticercosis under treatment with praziquantel: comparison with complement fixation reactions and immunofluorescence].
Topics: Adolescent; Adult; Central Nervous System Diseases; Complement Fixation Tests; Cysticercosis; Enzyme | 1985 |
Shifting CNS symptoms in a chronic alcoholic.
Topics: Adult; Alcoholism; Central Nervous System Diseases; Cysticercosis; Dexamethasone; Humans; Male; Phen | 1985 |
Praziquantel in treatment of cysticercosis cellulosae. Report of 200 cases.
Topics: Adolescent; Adult; Aged; Cysticercosis; Female; Humans; Male; Middle Aged; Praziquantel | 1985 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-1986. A 34-year-old Honduran immigrant woman with intermittent right facial numbness.
Topics: Adrenal Cortex Hormones; Adult; Brain; Brain Diseases; Brain Neoplasms; Cysticercosis; Diagnosis, Di | 1986 |
Niclosamide therapy for tapeworm infections.
Topics: Adult; Animals; Cestode Infections; Child; Cysticercosis; Dogs; Fishes; Humans; Meat; Niclosamide; P | 1985 |
Praziquantel in the treatment of neurocysticercosis: long-term follow-up.
Topics: Adolescent; Adult; Arachnoiditis; Brain Diseases; Cerebrospinal Fluid Proteins; Cysticercosis; Cysts | 1985 |
[Treatment and follow up of 50 cases of cerebral cysticercosis with praziquantel].
Topics: Adult; Brain Diseases; Cysticercosis; Female; Follow-Up Studies; Humans; Isoquinolines; Male; Middle | 1985 |
Neurocysticercosis--a comprehensive approach to medical treatment.
Topics: Adult; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Female; Humans; Isoquinolines; Male | 1985 |
Advances in the treatment of cysticercosis: praziquantel.
Topics: Cysticercosis; Humans; Isoquinolines; Praziquantel | 1985 |
Effect of praziquantel on intraocular cysticercosis: a case report.
Topics: Administration, Oral; Cysticercosis; Eye Diseases; Humans; Male; Middle Aged; Praziquantel | 1985 |
Praziquantel for cysticercotic arachnoiditis?
Topics: Arachnoiditis; Cysticercosis; Humans; Praziquantel | 1985 |
Spinal cysticercosis: a case report and its treatment with praziquantel.
Topics: Cysticercosis; Female; Humans; Middle Aged; Praziquantel; Spinal Cord Diseases | 1985 |
Praziquantel in the cerebrospinal fluid in neurocysticercosis.
Topics: Adolescent; Adult; Blood-Brain Barrier; Central Nervous System Diseases; Cysticercosis; Female; Huma | 1985 |
Praziquantel in neurocysticercosis.
Topics: Adolescent; Adult; Cysticercosis; Female; Humans; Male; Middle Aged; Nervous System Diseases; Praziq | 1985 |
Treatment of cysticercosis with praziquantel at the Bangkok Hospital for Tropical Diseases.
Topics: Adult; Brain; Cysticercosis; Dexamethasone; Female; Humans; Male; Middle Aged; Praziquantel; Tomogra | 1985 |